,date,title,url
0,2000-03-29,西藏药业年报,/disclosure/listedinfo/announcement/c/600211_1999_0.pdf
1,2000-07-28,西藏药业半年报,/disclosure/listedinfo/announcement/c/600211_2000_1.pdf
2,2001-04-10,西藏药业年报,/disclosure/listedinfo/announcement/c/600211_2000_0.pdf
3,2001-06-11,西藏药业上市公司章程,/disclosure/listedinfo/announcement/c/600211_2001_g.pdf
4,2001-08-24,西藏药业半年报,/disclosure/listedinfo/announcement/c/600211_2001_1.pdf
5,2002-02-28,西藏药业年报,/disclosure/listedinfo/announcement/c/600211_2001_n.pdf
6,2002-04-20,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/600211_2002_1.pdf
7,2002-07-10,西藏药业股东大会会议资料,/disclosure/listedinfo/announcement/c/600211_20020710_1.pdf
8,2002-08-17,西藏药业半年报,/disclosure/listedinfo/announcement/c/2002-08-17/600211_2002_z.pdf
9,2002-09-14,西藏药业股东大会会议资料,/disclosure/listedinfo/announcement/c/2002-09-14/600211_20020914_1.pdf
10,2002-09-19,西藏药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2002-09-19/600211_20020919_1.pdf
11,2002-10-18,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2002-10-18/600211_2002_3.pdf
12,2003-03-21,西藏药业年报,/disclosure/listedinfo/announcement/c/2003-03-21/600211_2002_n.pdf
13,2003-04-23,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-23/600211_2003_1.pdf
14,2003-04-25,西藏药业股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-04-25/600211_20030425_1.pdf
15,2003-04-30,西藏药业股东大会决议公告,/disclosure/listedinfo/announcement/c/2003-04-30/600211_20030430_1.pdf
16,2003-08-01,西藏药业上市公司章程,/disclosure/listedinfo/announcement/c/2003-08-01/600211_20030801_g.pdf
17,2003-08-20,西藏药业半年报,/disclosure/listedinfo/announcement/c/2003-08-20/600211_2003_z.pdf
18,2003-10-24,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-24/600211_2003_3.pdf
19,2004-01-29,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2004-01-29/600211_20040129_2.pdf
20,2004-01-29,西藏药业公告,/disclosure/listedinfo/announcement/c/2004-01-29/600211_20040129_3.pdf
21,2004-01-29,西藏药业董事会决议公告暨召开股东大会通知,/disclosure/listedinfo/announcement/c/2004-01-29/600211_20040129_1.pdf
22,2004-02-28,西藏药业延期召开股东大会通知,/disclosure/listedinfo/announcement/c/2004-02-28/600211_20040228_1.pdf
23,2004-03-17,西藏药业股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-03-17/600211_20040317_1.pdf
24,2004-03-18,西藏药业2004年临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-03-18/600211_20040318_1.pdf
25,2004-03-18,西藏药业2004年第一次临时股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-03-18/600211_20040318_2.pdf
26,2004-04-09,西藏药业年报,/disclosure/listedinfo/announcement/c/2004-04-09/600211_2003_n.pdf
27,2004-04-09,西藏药业监事会决议公告,/disclosure/listedinfo/announcement/c/2004-04-09/600211_20040409_2.pdf
28,2004-04-09,西藏药业公告,/disclosure/listedinfo/announcement/c/2004-04-09/600211_20040409_3.pdf
29,2004-04-09,西藏药业董事会决议公告暨召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-04-09/600211_20040409_1.pdf
30,2004-04-22,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-22/600211_2004_1.pdf
31,2004-05-10,西藏药业2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-05-10/600211_20040510_1.pdf
32,2004-05-12,西藏药业2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-05-12/600211_20040512_1.pdf
33,2004-05-12,西藏药业2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-05-12/600211_20040512_2.pdf
34,2004-08-05,西藏药业半年报摘要,/disclosure/listedinfo/announcement/c/2004-08-05/600211_2004_zzy.pdf
35,2004-08-05,西藏药业半年报,/disclosure/listedinfo/announcement/c/2004-08-05/600211_2004_z.pdf
36,2004-09-29,西藏药业董事会决议公告,/disclosure/listedinfo/announcement/c/2004-09-29/600211_20040929_1.pdf
37,2004-10-21,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-21/600211_2004_3.pdf
38,2005-03-31,西藏药业年报摘要,/disclosure/listedinfo/announcement/c/2005-03-31/600211_2004_nzy.pdf
39,2005-03-31,西藏药业年报,/disclosure/listedinfo/announcement/c/2005-03-31/600211_2004_n.pdf
40,2005-03-31,西藏药业董事会决议公告暨召开2004年度股东大会的通知,/disclosure/listedinfo/announcement/c/2005-03-31/600211_20050331_1.pdf
41,2005-03-31,西藏药业2004年度监事会决议公告,/disclosure/listedinfo/announcement/c/2005-03-31/600211_20050331_2.pdf
42,2005-04-26,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2005-04-26/600211_20050426_1.pdf
43,2005-04-26,西藏药业董事会决议公告暨延期召开股东大会的通知,/disclosure/listedinfo/announcement/c/2005-04-26/600211_20050426_2.pdf
44,2005-04-26,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-26/600211_2005_1.pdf
45,2005-05-25,西藏药业2004年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2005-05-25/600211_20050525_1.pdf
46,2005-06-01,西藏药业2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-06-01/600211_20050601_1.pdf
47,2005-06-01,西藏药业2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-06-01/600211_20050601_2.pdf
48,2005-06-21,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2005-06-21/600211_20050621_1.pdf
49,2005-08-05,西藏药业半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-05/600211_2005_zzy.pdf
50,2005-08-05,西藏药业半年报,/disclosure/listedinfo/announcement/c/2005-08-05/600211_2005_z.pdf
51,2005-10-24,西藏药业董事会决议公告,/disclosure/listedinfo/announcement/c/2005-10-24/600211_20051024_1.pdf
52,2005-10-24,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-24/600211_2005_3.pdf
53,2005-10-26,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2005-10-26/600211_20051026_1.pdf
54,2005-12-21,西藏药业提示性公告,/disclosure/listedinfo/announcement/c/2005-12-21/600211_20051221_1.pdf
55,2005-12-21,西藏药业收购报告书摘要,/disclosure/listedinfo/announcement/c/2005-12-21/600211_20051221_2.pdf
56,2005-12-21,西藏药业股东减持持股变动报告书,/disclosure/listedinfo/announcement/c/2005-12-21/600211_20051221_3.pdf
57,2006-01-14,西藏药业业绩预告修正公告,/disclosure/listedinfo/announcement/c/2006-01-14/600211_20060114_1.pdf
58,2006-03-22,西藏药业年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2006-03-22/600211_2005_nzy.pdf
59,2006-03-22,西藏药业年报（修订版）,/disclosure/listedinfo/announcement/c/2006-03-22/600211_2005_n.pdf
60,2006-03-22,西藏药业控股股东及其他关联方占用资金情况的专项审核说明,/disclosure/listedinfo/announcement/c/2006-03-22/600211_20060322_3.pdf
61,2006-03-22,西藏药业监事会决议公告,/disclosure/listedinfo/announcement/c/2006-03-22/600211_20060322_2.pdf
62,2006-03-22,西藏药业董事会决议公告暨召开2005年度股东大会的通知,/disclosure/listedinfo/announcement/c/2006-03-22/600211_20060322_1.pdf
63,2006-03-23,西藏药业关于2005年年度报告的更正公告,/disclosure/listedinfo/announcement/c/2006-03-23/600211_20060323_1.pdf
64,2006-04-11,西藏药业董事会决议公告暨召开2005年度股东大会的补充通知,/disclosure/listedinfo/announcement/c/2006-04-11/600211_20060411_1.pdf
65,2006-04-11,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-11/600211_2006_1.pdf
66,2006-04-27,西藏药业2005年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-04-27/600211_20060427_2.pdf
67,2006-04-27,西藏药业2005年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-04-27/600211_20060427_1.pdf
68,2006-07-01,西藏药业大股东及关联方资金占用清欠公告,/disclosure/listedinfo/announcement/c/2006-07-01/600211_20060701_1.pdf
69,2006-08-23,西藏药业半年报摘要,/disclosure/listedinfo/announcement/c/2006-08-23/600211_2006_zzy.pdf
70,2006-08-23,西藏药业半年报,/disclosure/listedinfo/announcement/c/2006-08-23/600211_2006_z.pdf
71,2006-09-21,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2006-09-21/600211_20060921_1.pdf
72,2006-09-23,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2006-09-23/600211_20060923_1.pdf
73,2006-09-27,西藏药业公告,/disclosure/listedinfo/announcement/c/2006-09-27/600211_20060927_1.pdf
74,2006-09-27,西藏药业董事会决议公告,/disclosure/listedinfo/announcement/c/2006-09-27/600211_20060927_2.pdf
75,2006-10-09,S藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2006-10-09/600211_20061009_1.pdf
76,2006-10-24,S藏药业业绩预计公告,/disclosure/listedinfo/announcement/c/2006-10-24/600211_20061024_1.pdf
77,2006-10-24,S藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-24/600211_2006_3.pdf
78,2006-12-25,S藏药业股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2006-12-25/600211_20061225_4.pdf
79,2006-12-25,S藏药业股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2006-12-25/600211_20061225_3.pdf
80,2006-12-25,S藏药业股权分置改革说明书,/disclosure/listedinfo/announcement/c/2006-12-25/600211_20061225_2.pdf
81,2006-12-25,S藏药业股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2006-12-25/600211_20061225_5.pdf
82,2006-12-25,S藏药业公告,/disclosure/listedinfo/announcement/c/2006-12-25/600211_20061225_1.pdf
83,2006-12-25,S藏药业独立董事关于股权分置改革之独立意见,/disclosure/listedinfo/announcement/c/2006-12-25/600211_20061225_6.pdf
84,2006-12-28,S藏药业公告,/disclosure/listedinfo/announcement/c/2006-12-28/600211_20061228_1.pdf
85,2007-01-05,S藏药业关于股权分置改革方案沟通情况的公告,/disclosure/listedinfo/announcement/c/2007-01-05/600211_20070105_1.pdf
86,2007-01-12,S藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-01-12/600211_20070112_2.pdf
87,2007-01-12,S藏药业重大事项补充公告,/disclosure/listedinfo/announcement/c/2007-01-12/600211_20070112_1.pdf
88,2007-01-13,S藏药业更正公告,/disclosure/listedinfo/announcement/c/2007-01-13/600211_20070113_1.pdf
89,2007-01-26,S藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-01-26/600211_20070126_1.pdf
90,2007-01-31,S藏药业关于召开股权分置改革相关股东会议的通知,/disclosure/listedinfo/announcement/c/2007-01-31/600211_20070131_1.pdf
91,2007-01-31,S藏药业股权分置改革董事会投票委托征集函,/disclosure/listedinfo/announcement/c/2007-01-31/600211_20070131_2.pdf
92,2007-02-02,S藏药业关于取消召开股权分置改革相关股东会议的通知,/disclosure/listedinfo/announcement/c/2007-02-02/600211_20070202_1.pdf
93,2007-03-31,S藏药业重大诉讼事项公告,/disclosure/listedinfo/announcement/c/2007-03-31/600211_20070331_1.pdf
94,2007-04-28,S藏药业年报摘要,/disclosure/listedinfo/announcement/c/2007-04-28/600211_2006_nzy.pdf
95,2007-04-28,S藏药业年报,/disclosure/listedinfo/announcement/c/2007-04-28/600211_2006_n.pdf
96,2007-04-28,S藏药业控股股东及其他关联方占用资金情况专项审核说明,/disclosure/listedinfo/announcement/c/2007-04-28/600211_20070428_4.pdf
97,2007-04-28,S藏药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-28/600211_20070428_2.pdf
98,2007-04-28,S藏药业关联交易公告,/disclosure/listedinfo/announcement/c/2007-04-28/600211_20070428_3.pdf
99,2007-04-28,S藏药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-28/600211_20070428_1.pdf
100,2007-04-30,S藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-30/600211_2007_1.pdf
101,2007-05-23,S藏药业关于召开2006年度股东大会的通知,/disclosure/listedinfo/announcement/c/2007-05-23/600211_20070523_1.pdf
102,2007-05-31,S藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-05-31/600211_20070531_1.pdf
103,2007-06-06,S藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-06-06/600211_20070606_1.pdf
104,2007-06-06,S藏药业2006年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-06-06/600211_20070606_2.pdf
105,2007-06-13,S藏药业有关股票临时停牌的公告,/disclosure/listedinfo/announcement/c/2007-06-13/600211_20070613_1.pdf
106,2007-06-20,S藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-06-20/600211_20070620_2.pdf
107,2007-06-20,S藏药业有关股权分置改革的公告,/disclosure/listedinfo/announcement/c/2007-06-20/600211_20070620_3.pdf
108,2007-06-20,S藏药业2006年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-06-20/600211_20070620_4.pdf
109,2007-06-20,S藏药业2006年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-06-20/600211_20070620_1.pdf
110,2007-06-22,S藏药业详式权益变动报告书,/disclosure/listedinfo/announcement/c/2007-06-22/600211_20070622_1.pdf
111,2007-06-22,S藏药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2007-06-22/600211_20070622_2.pdf
112,2007-06-26,S藏药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-26/600211_20070626_1.pdf
113,2007-06-28,S藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-06-28/600211_20070628_1.pdf
114,2007-06-30,S藏药业信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2007-06-30/600211_20070630_2.pdf
115,2007-06-30,S藏药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-30/600211_20070630_1.pdf
116,2007-06-30,S藏药业董事、监事和高级管理人员所持公司股份管理规则,/disclosure/listedinfo/announcement/c/2007-06-30/600211_20070630_3.pdf
117,2007-07-17,S藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-07-17/600211_20070717_1.pdf
118,2007-07-17,S藏药业2007年中期业绩预告,/disclosure/listedinfo/announcement/c/2007-07-17/600211_20070717_2.pdf
119,2007-07-19,S藏药业关于召开股权分置改革相关股东会议的通知,/disclosure/listedinfo/announcement/c/2007-07-19/600211_20070719_1.pdf
120,2007-07-19,S藏药业股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2007-07-19/600211_20070719_3.pdf
121,2007-07-19,S藏药业股权分置改革说明书,/disclosure/listedinfo/announcement/c/2007-07-19/600211_20070719_2.pdf
122,2007-07-19,S藏药业股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2007-07-19/600211_20070719_5.pdf
123,2007-07-19,S藏药业股权分置改革保荐意见书,/disclosure/listedinfo/announcement/c/2007-07-19/600211_20070719_4.pdf
124,2007-07-19,S藏药业独立董事意见函,/disclosure/listedinfo/announcement/c/2007-07-19/600211_20070719_6.pdf
125,2007-07-19,S藏药业董事会投票委托征集函,/disclosure/listedinfo/announcement/c/2007-07-19/600211_20070719_7.pdf
126,2007-07-27,S藏药业关于股权分置改革方案沟通协商结果暨调整股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2007-07-27/600211_20070727_1.pdf
127,2007-07-27,S藏药业股权分置改革之补充法律意见书,/disclosure/listedinfo/announcement/c/2007-07-27/600211_20070727_5.pdf
128,2007-07-27,S藏药业股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2007-07-27/600211_20070727_3.pdf
129,2007-07-27,S藏药业股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2007-07-27/600211_20070727_2.pdf
130,2007-07-27,S藏药业股权分置改革补充保荐意见书,/disclosure/listedinfo/announcement/c/2007-07-27/600211_20070727_4.pdf
131,2007-07-31,S藏药业关于召开股权分置改革相关股东会议第一次提示性公告,/disclosure/listedinfo/announcement/c/2007-07-31/600211_20070731_1.pdf
132,2007-08-08,S藏药业关于召开股权分置改革相关股东会议第二次提示性公告,/disclosure/listedinfo/announcement/c/2007-08-08/600211_20070808_1.pdf
133,2007-08-08,S藏药业关于股权分置改革方案获准的公告,/disclosure/listedinfo/announcement/c/2007-08-08/600211_20070808_2.pdf
134,2007-08-15,S藏药业重大诉讼事项公告,/disclosure/listedinfo/announcement/c/2007-08-15/600211_20070815_2.pdf
135,2007-08-15,S藏药业股权分置改革相关股东会议法律意见书,/disclosure/listedinfo/announcement/c/2007-08-15/600211_20070815_3.pdf
136,2007-08-15,S藏药业股权分置改革相关股东会议表决结果公告,/disclosure/listedinfo/announcement/c/2007-08-15/600211_20070815_1.pdf
137,2007-08-24,S藏药业半年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2007-08-24/600211_2007_zzy.pdf
138,2007-08-24,S藏药业半年报（修订版）,/disclosure/listedinfo/announcement/c/2007-08-24/600211_2007_z.pdf
139,2007-08-28,S藏药业2007年中期报告更正公告,/disclosure/listedinfo/announcement/c/2007-08-28/600211_20070828_1.pdf
140,2007-09-04,S藏药业关于加强上市公司治理专项活动自查报告及整改计划,/disclosure/listedinfo/announcement/c/2007-09-04/600211_20070904_1.pdf
141,2007-09-06,S藏药业股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2007-09-06/600211_20070906_1.pdf
142,2007-09-07,S藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-09-07/600211_20070907_1.pdf
143,2007-09-13,西藏药业重大诉讼事项公告,/disclosure/listedinfo/announcement/c/2007-09-13/600211_20070913_1.pdf
144,2007-09-13,西藏药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-09-13/600211_20070913_2.pdf
145,2007-09-14,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-09-14/600211_20070914_1.pdf
146,2007-09-20,西藏药业2007年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-09-20/600211_20070920_1.pdf
147,2007-09-21,西藏药业重大诉讼事项公告,/disclosure/listedinfo/announcement/c/2007-09-21/600211_20070921_2.pdf
148,2007-09-21,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-09-21/600211_20070921_1.pdf
149,2007-09-29,西藏药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-09-29/600211_20070929_3.pdf
150,2007-09-29,西藏药业董事会决议公告暨召开临时股东大会的通知,/disclosure/listedinfo/announcement/c/2007-09-29/600211_20070929_2.pdf
151,2007-09-29,西藏药业2007年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-09-29/600211_20070929_1.pdf
152,2007-09-29,西藏药业2007年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-09-29/600211_20070929_4.pdf
153,2007-10-09,西藏药业2007年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-10-09/600211_20071009_1.pdf
154,2007-10-16,西藏药业监事会决议公告,/disclosure/listedinfo/announcement/c/2007-10-16/600211_20071016_3.pdf
155,2007-10-16,西藏药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-10-16/600211_20071016_2.pdf
156,2007-10-16,西藏药业2007年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-10-16/600211_20071016_1.pdf
157,2007-10-16,西藏药业2007年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-10-16/600211_20071016_4.pdf
158,2007-10-25,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-25/600211_2007_3.pdf
159,2007-10-25,西藏药业2007年年度业绩预亏公告,/disclosure/listedinfo/announcement/c/2007-10-25/600211_20071025_1.pdf
160,2007-11-07,西藏药业股票价格异常波动的公告,/disclosure/listedinfo/announcement/c/2007-11-07/600211_20071107_1.pdf
161,2007-11-14,西藏药业关于中国证监会西藏监管局现场检查发现问题的整改报告,/disclosure/listedinfo/announcement/c/2007-11-14/600211_20071114_2.pdf
162,2007-11-14,西藏药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-11-14/600211_20071114_1.pdf
163,2007-11-16,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2007-11-16/600211_20071116_1.pdf
164,2007-11-29,西藏药业重大诉讼事项进展公告,/disclosure/listedinfo/announcement/c/2007-11-29/600211_20071129_1.pdf
165,2007-12-05,西藏药业重大诉讼事项进展公告,/disclosure/listedinfo/announcement/c/2007-12-05/600211_20071205_1.pdf
166,2007-12-12,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2007-12-12/600211_20071212_1.pdf
167,2007-12-26,西藏药业有关治理专项活动整改报告,/disclosure/listedinfo/announcement/c/2007-12-26/600211_20071226_2.pdf
168,2007-12-26,西藏药业董事会决议公告,/disclosure/listedinfo/announcement/c/2007-12-26/600211_20071226_1.pdf
169,2008-01-17,西藏药业股票价格异常波动的公告,/disclosure/listedinfo/announcement/c/2008-01-17/600211_20080117_1.pdf
170,2008-01-30,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2008-01-30/600211_20080130_2.pdf
171,2008-01-30,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2008-01-30/600211_20080130_1.pdf
172,2008-02-25,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2008-02-25/600211_20080225_1.pdf
173,2008-02-26,西藏药业重大事项提示性公告,/disclosure/listedinfo/announcement/c/2008-02-26/600211_20080226_1.pdf
174,2008-02-29,西藏药业股票停牌公告,/disclosure/listedinfo/announcement/c/2008-02-29/600211_20080229_1.pdf
175,2008-03-03,西藏药业股票停牌公告,/disclosure/listedinfo/announcement/c/2008-03-03/600211_20080303_1.pdf
176,2008-03-04,西藏药业股票停牌公告,/disclosure/listedinfo/announcement/c/2008-03-04/600211_20080304_1.pdf
177,2008-03-04,西藏药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-03-04/600211_20080304_2.pdf
178,2008-03-05,西藏药业股改后续事项的进展公告,/disclosure/listedinfo/announcement/c/2008-03-05/600211_20080305_1.pdf
179,2008-03-07,西藏药业股份被冻结的公告,/disclosure/listedinfo/announcement/c/2008-03-07/600211_20080307_1.pdf
180,2008-03-11,西藏药业重大合同公告,/disclosure/listedinfo/announcement/c/2008-03-11/600211_20080311_1.pdf
181,2008-04-01,西藏药业重大诉讼事项进展公告,/disclosure/listedinfo/announcement/c/2008-04-01/600211_20080401_1.pdf
182,2008-04-22,西藏药业与香港确思医药投资控股有限公司签署《补充协议》的公告,/disclosure/listedinfo/announcement/c/2008-04-22/600211_20080422_3.pdf
183,2008-04-22,西藏药业审计委员会工作规程,/disclosure/listedinfo/announcement/c/2008-04-22/600211_20080422_7.pdf
184,2008-04-22,西藏药业年报摘要,/disclosure/listedinfo/announcement/c/2008-04-22/600211_2007_nzy.pdf
185,2008-04-22,西藏药业年报,/disclosure/listedinfo/announcement/c/2008-04-22/600211_2007_n.pdf
186,2008-04-22,西藏药业控股股东及其他关联方占用资金情况专项审核说明,/disclosure/listedinfo/announcement/c/2008-04-22/600211_20080422_5.pdf
187,2008-04-22,西藏药业监事会决议公告,/disclosure/listedinfo/announcement/c/2008-04-22/600211_20080422_2.pdf
188,2008-04-22,西藏药业关于前次募集资金使用情况的专项说明的公告,/disclosure/listedinfo/announcement/c/2008-04-22/600211_20080422_4.pdf
189,2008-04-22,西藏药业独立董事年报工作制度,/disclosure/listedinfo/announcement/c/2008-04-22/600211_20080422_6.pdf
190,2008-04-22,西藏药业董事会决议公告暨关于召开2007年度股东大会的通知,/disclosure/listedinfo/announcement/c/2008-04-22/600211_20080422_1.pdf
191,2008-04-22,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-22/600211_2008_1.pdf
192,2008-05-05,西藏药业重大诉讼事项公告,/disclosure/listedinfo/announcement/c/2008-05-05/600211_20080505_1.pdf
193,2008-05-09,西藏药业大股东所持股份被质押的公告,/disclosure/listedinfo/announcement/c/2008-05-09/600211_20080509_1.pdf
194,2008-05-10,西藏药业2007年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-05-10/600211_20080510_1.pdf
195,2008-05-15,西藏药业股票价格异常波动的公告,/disclosure/listedinfo/announcement/c/2008-05-15/600211_20080515_1.pdf
196,2008-05-17,西藏药业2007年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-05-17/600211_20080517_1.pdf
197,2008-05-17,西藏药业2007年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-05-17/600211_20080517_2.pdf
198,2008-06-07,西藏药业股改后续事项的进展公告（二）,/disclosure/listedinfo/announcement/c/2008-06-07/600211_20080607_1.pdf
199,2008-06-19,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2008-06-19/600211_20080619_1.pdf
200,2008-06-25,西藏药业董事会关于聘任总经理的公告,/disclosure/listedinfo/announcement/c/2008-06-25/600211_20080625_1.pdf
201,2008-06-26,西藏药业重大事项进展公告,/disclosure/listedinfo/announcement/c/2008-06-26/600211_20080626_1.pdf
202,2008-07-19,西藏药业有关治理专项活动整改情况说明,/disclosure/listedinfo/announcement/c/2008-07-19/600211_20080719_2.pdf
203,2008-07-19,西藏药业董事会决议公告,/disclosure/listedinfo/announcement/c/2008-07-19/600211_20080719_1.pdf
204,2008-08-06,西藏药业重大事项进展公告,/disclosure/listedinfo/announcement/c/2008-08-06/600211_20080806_1.pdf
205,2008-08-15,西藏药业半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-15/600211_2008_zzy.pdf
206,2008-08-15,西藏药业半年报,/disclosure/listedinfo/announcement/c/2008-08-15/600211_2008_z.pdf
207,2008-09-09,西藏药业有限售条件的流通股上市流通公告,/disclosure/listedinfo/announcement/c/2008-09-09/600211_20080909_1.pdf
208,2008-09-13,西藏药业重大诉讼事项进展公告,/disclosure/listedinfo/announcement/c/2008-09-13/600211_20080913_1.pdf
209,2008-09-17,西藏药业更正公告,/disclosure/listedinfo/announcement/c/2008-09-17/600211_20080917_1.pdf
210,2008-09-25,西藏药业重大诉讼事项公告,/disclosure/listedinfo/announcement/c/2008-09-25/600211_20080925_1.pdf
211,2008-09-25,西藏药业关于股东持有股份解除冻结的公告,/disclosure/listedinfo/announcement/c/2008-09-25/600211_20080925_2.pdf
212,2008-10-23,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2008-10-23/600211_20081023_1.pdf
213,2008-10-24,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-24/600211_2008_3.pdf
214,2008-11-11,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2008-11-11/600211_20081111_1.pdf
215,2008-11-11,西藏药业股份被冻结的公告,/disclosure/listedinfo/announcement/c/2008-11-11/600211_20081111_2.pdf
216,2008-11-29,西藏药业信息披露事务管理制度,/disclosure/listedinfo/announcement/c/2008-11-29/600211_20081129_2.pdf
217,2008-11-29,西藏药业防范大股东及关联方资金占用管理办法,/disclosure/listedinfo/announcement/c/2008-11-29/600211_20081129_3.pdf
218,2008-11-29,西藏药业第三届董事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2008-11-29/600211_20081129_1.pdf
219,2008-12-03,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2008-12-03/600211_20081203_1.pdf
220,2009-01-23,西藏药业业绩预盈公告,/disclosure/listedinfo/announcement/c/2009-01-23/600211_20090123_1.pdf
221,2009-02-13,西藏药业关于第三届董事会第十一次会议决议公告暨召开2009年第一次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2009-02-13/600211_20090213_1.pdf
222,2009-02-19,西藏药业重大诉讼事项进展公告,/disclosure/listedinfo/announcement/c/2009-02-19/600211_20090219_1.pdf
223,2009-02-21,西藏药业2009年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-02-21/600211_20090221_1.pdf
224,2009-03-03,西藏药业2009年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-03-03/600211_20090303_1.pdf
225,2009-03-03,西藏药业2009年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-03-03/600211_20090303_2.pdf
226,2009-03-17,西藏药业第三届董事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2009-03-17/600211_20090317_1.pdf
227,2009-04-17,西藏药业审计委员会工作规程,/disclosure/listedinfo/announcement/c/2009-04-17/600211_20090417_5.pdf
228,2009-04-17,西藏药业年报摘要,/disclosure/listedinfo/announcement/c/2009-04-17/600211_2008_nzy.pdf
229,2009-04-17,西藏药业年报,/disclosure/listedinfo/announcement/c/2009-04-17/600211_2008_n.pdf
230,2009-04-17,西藏药业控股股东及其他关联方占用资金情况专项审核说明,/disclosure/listedinfo/announcement/c/2009-04-17/600211_20090417_3.pdf
231,2009-04-17,西藏药业金融工具公允价值确定的管理办法,/disclosure/listedinfo/announcement/c/2009-04-17/600211_20090417_4.pdf
232,2009-04-17,西藏药业第三届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2009-04-17/600211_20090417_2.pdf
233,2009-04-17,西藏药业第三届董事会第十三次会议决议公告暨召开公司2008年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2009-04-17/600211_20090417_1.pdf
234,2009-04-23,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-23/600211_2009_1.pdf
235,2009-05-08,西藏药业2008年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-05-08/600211_20090508_1.pdf
236,2009-05-16,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2009-05-16/600211_20090516_1.pdf
237,2009-05-16,西藏药业公司章程（2009修订）,/disclosure/listedinfo/announcement/c/2009-05-16/600211_20090516_g.pdf
238,2009-05-16,西藏药业2008年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-05-16/600211_20090516_3.pdf
239,2009-05-16,西藏药业2008年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-05-16/600211_20090516_2.pdf
240,2009-06-03,西藏药业重大资产重组及连续停牌公告,/disclosure/listedinfo/announcement/c/2009-06-03/600211_20090603_1.pdf
241,2009-06-15,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2009-06-15/600211_20090615_1.pdf
242,2009-06-22,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2009-06-22/600211_20090622_1.pdf
243,2009-06-29,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2009-06-29/600211_20090629_1.pdf
244,2009-07-03,西藏药业关于召开2009年第二次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2009-07-03/600211_20090703_2.pdf
245,2009-07-03,西藏药业关于第三届董事会临时会议决议暨重大资产重组进展情况公告,/disclosure/listedinfo/announcement/c/2009-07-03/600211_20090703_1.pdf
246,2009-07-15,西藏药业2009年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-07-15/600211_20090715_1.pdf
247,2009-07-21,西藏药业2009年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-07-21/600211_20090721_1.pdf
248,2009-07-21,西藏药业2009年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-07-21/600211_20090721_2.pdf
249,2009-07-29,西藏药业关于媒体报道的说明公告,/disclosure/listedinfo/announcement/c/2009-07-29/600211_20090729_1.pdf
250,2009-07-30,西藏药业重大诉讼事项进展公告,/disclosure/listedinfo/announcement/c/2009-07-30/600211_20090730_1.pdf
251,2009-08-18,西藏药业重大诉讼事项进展公告,/disclosure/listedinfo/announcement/c/2009-08-18/600211_20090818_1.pdf
252,2009-08-18,西藏药业临时董事会决议公告暨召开2009年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2009-08-18/600211_20090818_2.pdf
253,2009-08-18,西藏药业半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-18/600211_2009_zzy.pdf
254,2009-08-18,西藏药业半年报,/disclosure/listedinfo/announcement/c/2009-08-18/600211_2009_z.pdf
255,2009-08-28,西藏药业2009年第三次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-08-28/600211_20090828_1.pdf
256,2009-09-04,西藏药业2009年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-09-04/600211_20090904_1.pdf
257,2009-09-04,西藏药业2009年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-09-04/600211_20090904_2.pdf
258,2009-10-20,西藏药业第三届董事会第十七次会议决议公告,/disclosure/listedinfo/announcement/c/2009-10-20/600211_20091020_1.pdf
259,2009-10-20,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-20/600211_2009_3.pdf
260,2009-11-14,西藏药业第三届董事会第十八次会议决议公告,/disclosure/listedinfo/announcement/c/2009-11-14/600211_20091114_1.pdf
261,2010-02-06,西藏药业第三届监事会关于选举职工监事的公告,/disclosure/listedinfo/announcement/c/2010-02-06/600211_20100206_2.pdf
262,2010-02-06,西藏药业第三届董事会关于聘任董事会秘书的公告,/disclosure/listedinfo/announcement/c/2010-02-06/600211_20100206_1.pdf
263,2010-02-23,西藏药业关于出售资产的公告,/disclosure/listedinfo/announcement/c/2010-02-23/600211_20100223_1.pdf
264,2010-03-10,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2010-03-10/600211_20100310_1.pdf
265,2010-03-13,西藏药业关于出售资产合同的进展公告,/disclosure/listedinfo/announcement/c/2010-03-13/600211_20100313_1.pdf
266,2010-03-23,西藏药业外部信息使用人管理制度,/disclosure/listedinfo/announcement/c/2010-03-23/600211_20100323_5.pdf
267,2010-03-23,西藏药业年报摘要,/disclosure/listedinfo/announcement/c/2010-03-23/600211_2009_nzy.pdf
268,2010-03-23,西藏药业年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-03-23/600211_20100323_9.pdf
269,2010-03-23,西藏药业年报,/disclosure/listedinfo/announcement/c/2010-03-23/600211_2009_n.pdf
270,2010-03-23,西藏药业内幕信息知情人管理制度,/disclosure/listedinfo/announcement/c/2010-03-23/600211_20100323_6.pdf
271,2010-03-23,西藏药业关于为四川本草堂药业有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2010-03-23/600211_20100323_3.pdf
272,2010-03-23,西藏药业独立董事工作制度,/disclosure/listedinfo/announcement/c/2010-03-23/600211_20100323_8.pdf
273,2010-03-23,西藏药业董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2010-03-23/600211_20100323_7.pdf
274,2010-03-23,西藏药业第三届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2010-03-23/600211_20100323_2.pdf
275,2010-03-23,西藏药业第三届董事会第二十次会议决议公告暨召开公司2009年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2010-03-23/600211_20100323_1.pdf
276,2010-03-23,西藏药业2009年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2010-03-23/600211_20100323_4.pdf
277,2010-04-14,西藏药业2009年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-04-14/600211_20100414_1.pdf
278,2010-04-20,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-20/600211_2010_1.pdf
279,2010-04-20,西藏药业2009年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-04-20/600211_20100420_2.pdf
280,2010-04-20,西藏药业2009年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-04-20/600211_20100420_1.pdf
281,2010-04-21,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2010-04-21/600211_20100421_1.pdf
282,2010-06-19,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2010-06-19/600211_20100619_1.pdf
283,2010-06-24,西藏药业第三届董事会第二十二次会议决议公告暨召开股权分置改革方案之后续安排方案相关股东会议的通知,/disclosure/listedinfo/announcement/c/2010-06-24/600211_20100624_1.pdf
284,2010-06-30,西藏药业关于大股东持有股份被解除质押的公告,/disclosure/listedinfo/announcement/c/2010-06-30/600211_20100630_1.pdf
285,2010-07-02,西藏药业关于大股东持有股份被解除冻结和被质押的公告,/disclosure/listedinfo/announcement/c/2010-07-02/600211_20100702_1.pdf
286,2010-07-03,西藏药业关于大股东持有股份被质押的公告,/disclosure/listedinfo/announcement/c/2010-07-03/600211_20100703_1.pdf
287,2010-07-06,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2010-07-06/600211_20100706_1.pdf
288,2010-07-13,西藏药业关于召开股权分置改革方案之后续安排方案相关股东会议第一次提示性公告,/disclosure/listedinfo/announcement/c/2010-07-13/600211_20100713_1.pdf
289,2010-07-21,西藏药业股权分置改革方案之后续安排方案相关股东会议资料,/disclosure/listedinfo/announcement/c/2010-07-21/600211_20100721_1.pdf
290,2010-07-22,西藏药业关于召开股权分置改革方案之后续安排方案相关股东会议第二次提示性公告,/disclosure/listedinfo/announcement/c/2010-07-22/600211_20100722_1.pdf
291,2010-07-27,西藏药业股权分置改革方案之后续安排方案相关股东会议之法律意见书,/disclosure/listedinfo/announcement/c/2010-07-27/600211_20100727_2.pdf
292,2010-07-27,西藏药业股权分置改革方案之后续安排方案相关股东会议表决结果公告,/disclosure/listedinfo/announcement/c/2010-07-27/600211_20100727_1.pdf
293,2010-07-28,西藏药业半年报摘要,/disclosure/listedinfo/announcement/c/2010-07-28/600211_2010_zzy.pdf
294,2010-07-28,西藏药业半年报,/disclosure/listedinfo/announcement/c/2010-07-28/600211_2010_z.pdf
295,2010-09-01,西藏药业股权分置改革方案之后续安排方案实施公告,/disclosure/listedinfo/announcement/c/2010-09-01/600211_20100901_1.pdf
296,2010-10-27,西藏药业关于大股东持有股份被冻结的公告,/disclosure/listedinfo/announcement/c/2010-10-27/600211_20101027_1.pdf
297,2010-10-27,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-27/600211_2010_3.pdf
298,2010-11-09,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2010-11-09/600211_20101109_1.pdf
299,2010-11-09,西藏药业2010年年度业绩预亏公告,/disclosure/listedinfo/announcement/c/2010-11-09/600211_20101109_2.pdf
300,2010-11-19,西藏药业关于大股东持有股份被解除质押的公告,/disclosure/listedinfo/announcement/c/2010-11-19/600211_20101119_1.pdf
301,2010-11-23,西藏药业关于大股东持有股份被质押的公告,/disclosure/listedinfo/announcement/c/2010-11-23/600211_20101123_1.pdf
302,2010-11-30,西藏药业关于本公司股票价格异常波动的公告,/disclosure/listedinfo/announcement/c/2010-11-30/600211_20101130_1.pdf
303,2011-01-25,西藏药业关于监事会换届选举的公告,/disclosure/listedinfo/announcement/c/2011-01-25/600211_20110125_2.pdf
304,2011-01-25,西藏药业第三届董事会第二十五次会议决议公告暨召开2011年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-01-25/600211_20110125_1.pdf
305,2011-02-15,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2011-02-15/600211_20110215_1.pdf
306,2011-02-15,西藏药业2011年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-02-15/600211_20110215_2.pdf
307,2011-02-22,西藏药业公司章程（2011修订）,/disclosure/listedinfo/announcement/c/2011-02-22/600211_20110222_g.pdf
308,2011-02-22,西藏药业第四届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2011-02-22/600211_20110222_3.pdf
309,2011-02-22,西藏药业第四届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2011-02-22/600211_20110222_2.pdf
310,2011-02-22,西藏药业2011年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-02-22/600211_20110222_1.pdf
311,2011-02-22,西藏药业2011年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-02-22/600211_20110222_4.pdf
312,2011-03-30,西藏药业第四届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-03-30/600211_20110330_1.pdf
313,2011-04-08,西藏药业重大诉讼事项进展及业绩预告更正公告,/disclosure/listedinfo/announcement/c/2011-04-08/600211_20110408_1.pdf
314,2011-04-22,西藏药业年报摘要,/disclosure/listedinfo/announcement/c/2011-04-22/600211_2010_nzy.pdf
315,2011-04-22,西藏药业年报,/disclosure/listedinfo/announcement/c/2011-04-22/600211_2010_n.pdf
316,2011-04-22,西藏药业第四届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2011-04-22/600211_20110422_2.pdf
317,2011-04-22,西藏药业第四届董事会第三次会议决议公告暨召开公司2010年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2011-04-22/600211_20110422_1.pdf
318,2011-04-22,西藏药业2010年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2011-04-22/600211_20110422_3.pdf
319,2011-04-27,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-27/600211_2011_1.pdf
320,2011-05-04,西藏药业关联交易制度,/disclosure/listedinfo/announcement/c/2011-05-04/600211_20110504_3.pdf
321,2011-05-04,西藏药业董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2011-05-04/600211_20110504_2.pdf
322,2011-05-04,西藏药业第四届董事会第五次会议决议公告,/disclosure/listedinfo/announcement/c/2011-05-04/600211_20110504_1.pdf
323,2011-05-07,西藏药业2010年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-05-07/600211_20110507_1.pdf
324,2011-05-14,西藏药业2010年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-05-14/600211_20110514_1.pdf
325,2011-05-14,西藏药业2010年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-05-14/600211_20110514_2.pdf
326,2011-05-20,西藏药业关于大股东持有股份被冻结的公告,/disclosure/listedinfo/announcement/c/2011-05-20/600211_20110520_1.pdf
327,2011-07-28,西藏药业关于控股子公司四川本草堂药业有限公司对外投资的进展公告,/disclosure/listedinfo/announcement/c/2011-07-28/600211_20110728_1.pdf
328,2011-07-30,西藏药业半年报摘要,/disclosure/listedinfo/announcement/c/2011-07-30/600211_2011_zzy.pdf
329,2011-07-30,西藏药业半年报,/disclosure/listedinfo/announcement/c/2011-07-30/600211_2011_z.pdf
330,2011-08-03,西藏药业关于为四川本草堂药业有限公司提供担保的公告暨召开2011年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-08-03/600211_20110803_1.pdf
331,2011-08-11,西藏药业第四届董事会关于聘任副总经理的公告,/disclosure/listedinfo/announcement/c/2011-08-11/600211_20110811_1.pdf
332,2011-08-13,西藏药业2011年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-08-13/600211_20110813_1.pdf
333,2011-08-20,西藏药业2011年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-08-20/600211_20110820_1.pdf
334,2011-08-20,西藏药业2011年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-08-20/600211_20110820_2.pdf
335,2011-08-30,西藏药业第四届董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2011-08-30/600211_20110830_1.pdf
336,2011-09-01,西藏药业有限售条件的流通股上市流通公告,/disclosure/listedinfo/announcement/c/2011-09-01/600211_20110901_1.pdf
337,2011-10-25,西藏药业第四届董事会第八次会议决议公告,/disclosure/listedinfo/announcement/c/2011-10-25/600211_20111025_1.pdf
338,2011-10-25,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-25/600211_2011_3.pdf
339,2011-12-24,西藏药业第四届董事会第九次会议决议公告暨召开2012年第一次临时股东大会的公告,/disclosure/listedinfo/announcement/c/2011-12-24/600211_20111224_1.pdf
340,2012-01-06,西藏药业2012年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-01-06/600211_20120106_1.pdf
341,2012-01-12,西藏药业2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-01-12/600211_20120112_1.pdf
342,2012-01-12,西藏药业2012年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-01-12/600211_20120112_2.pdf
343,2012-03-28,西藏药业年报摘要,/disclosure/listedinfo/announcement/c/2012-03-28/600211_2011_nzy.pdf
344,2012-03-28,西藏药业年报,/disclosure/listedinfo/announcement/c/2012-03-28/600211_2011_n.pdf
345,2012-03-28,西藏药业第四届监事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2012-03-28/600211_20120328_2.pdf
346,2012-03-28,西藏药业第四届董事会第十次会议决议公告暨召开公司2011年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2012-03-28/600211_20120328_1.pdf
347,2012-03-28,西藏药业2011年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2012-03-28/600211_20120328_3.pdf
348,2012-03-28,西藏药业2011年度独立董事述职报告,/disclosure/listedinfo/announcement/c/2012-03-28/600211_20120328_4.pdf
349,2012-04-13,西藏药业2011年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-04-13/600211_20120413_1.pdf
350,2012-04-19,西藏药业2011年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-04-19/600211_20120419_1.pdf
351,2012-04-19,西藏药业2011年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-04-19/600211_20120419_2.pdf
352,2012-04-21,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-21/600211_2012_1.pdf
353,2012-04-27,西藏药业关于大股东持有股份被解除质押的公告,/disclosure/listedinfo/announcement/c/2012-04-27/600211_20120427_1.pdf
354,2012-05-03,西藏药业关于大股东持有股份被质押的公告,/disclosure/listedinfo/announcement/c/2012-05-03/600211_20120503_1.pdf
355,2012-07-19,西藏药业重大诉讼事项公告,/disclosure/listedinfo/announcement/c/2012-07-19/600211_20120719_1.pdf
356,2012-08-03,西藏药业第四届董事会第十三次会议决议公告暨召开公司2012年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-08-03/600211_20120803_1.pdf
357,2012-08-03,西藏药业半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-03/600211_2012_zzy.pdf
358,2012-08-03,西藏药业半年报,/disclosure/listedinfo/announcement/c/2012-08-03/600211_2012_z.pdf
359,2012-08-15,西藏药业2012年第二次临时股东大会文件,/disclosure/listedinfo/announcement/c/2012-08-15/600211_20120815_1.pdf
360,2012-08-21,西藏药业公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-08-21/600211_20120821_g.pdf
361,2012-08-21,西藏药业2012年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-08-21/600211_20120821_1.pdf
362,2012-08-21,西藏药业2012年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-08-21/600211_20120821_2.pdf
363,2012-09-04,西藏药业有限售条件的流通股上市流通公告,/disclosure/listedinfo/announcement/c/2012-09-04/600211_20120904_1.pdf
364,2012-10-23,西藏药业关于大股东持有股份被冻结的公告,/disclosure/listedinfo/announcement/c/2012-10-23/600211_20121023_1.pdf
365,2012-10-26,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-26/600211_2012_3.pdf
366,2012-12-05,西藏药业关于为四川本草堂药业有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2012-12-05/600211_20121205_1.pdf
367,2012-12-05,西藏药业：四川本草堂药业有限公司最近一期的财务报表,/disclosure/listedinfo/announcement/c/2012-12-05/600211_20121205_2.pdf
368,2013-01-22,西藏药业第四届董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2013-01-21/600211_20130122_1.pdf
369,2013-02-06,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2013-02-05/600211_20130206_1.pdf
370,2013-03-19,西藏药业关于产品进入国家基本药物目录的公告,/disclosure/listedinfo/announcement/c/2013-03-18/600211_20130319_1.pdf
371,2013-03-29,西藏药业审计报告,/disclosure/listedinfo/announcement/c/2013-03-28/600211_20130329_6.pdf
372,2013-03-29,西藏药业年报摘要,/disclosure/listedinfo/announcement/c/2013-03-28/600211_2012_nzy.pdf
373,2013-03-29,西藏药业年报,/disclosure/listedinfo/announcement/c/2013-03-28/600211_2012_n.pdf
374,2013-03-29,西藏药业关于召开2012年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2013-03-28/600211_20130329_2.pdf
375,2013-03-29,西藏药业独立董事2012年度述职报告,/disclosure/listedinfo/announcement/c/2013-03-28/600211_20130329_5.pdf
376,2013-03-29,西藏药业第四届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-28/600211_20130329_3.pdf
377,2013-03-29,西藏药业第四届董事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2013-03-28/600211_20130329_1.pdf
378,2013-03-29,西藏药业2012年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2013-03-28/600211_20130329_7.pdf
379,2013-04-11,西藏药业2012年年度股东大会文件,/disclosure/listedinfo/announcement/c/2013-04-10/600211_20130411_1.pdf
380,2013-04-19,西藏药业2012年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-04-18/600211_20130419_1.pdf
381,2013-04-19,西藏药业2012年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-04-18/600211_20130419_2.pdf
382,2013-04-25,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-24/600211_2013_1.pdf
383,2013-05-11,西藏药业关于大股东持有股份被解除质押的公告,/disclosure/listedinfo/announcement/c/2013-05-10/600211_20130511_1.pdf
384,2013-05-21,西藏药业2012年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2013-05-20/600211_20130521_1.pdf
385,2013-06-04,西藏药业股份质押公告,/disclosure/listedinfo/announcement/c/2013-06-03/600211_20130604_1.pdf
386,2013-08-03,西藏药业半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-02/600211_2013_zzy.pdf
387,2013-08-03,西藏药业半年报,/disclosure/listedinfo/announcement/c/2013-08-02/600211_2013_z.pdf
388,2013-08-30,西藏药业关于2013年半年度报告的补充公告,/disclosure/listedinfo/announcement/c/2013-08-29/600211_20130830_2.pdf
389,2013-08-30,西藏药业半年报摘要（修订版）,/disclosure/listedinfo/announcement/c/2013-08-29/600211_2013_zzy.pdf
390,2013-08-30,西藏药业半年报（修订版）,/disclosure/listedinfo/announcement/c/2013-08-29/600211_2013_z.pdf
391,2013-09-05,西藏药业有限售条件的流通股上市流通申请的核查意见书,/disclosure/listedinfo/announcement/c/2013-09-04/600211_20130905_2.pdf
392,2013-09-05,西藏药业股改限售股上市流通公告,/disclosure/listedinfo/announcement/c/2013-09-04/600211_20130905_1.pdf
393,2013-10-26,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-25/600211_2013_3.pdf
394,2013-11-06,西藏药业关于收到西藏证监局《行政监管措施决定书》的公告,/disclosure/listedinfo/announcement/c/2013-11-05/600211_20131106_1.pdf
395,2013-11-14,西藏药业关于控股子公司获得银行授信的公告,/disclosure/listedinfo/announcement/c/2013-11-13/600211_20131114_1.pdf
396,2013-12-25,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2013-12-24/600211_20131225_2.pdf
397,2013-12-25,西藏药业关于西藏证监局对公司采取责令改正措施决定的整改报告,/disclosure/listedinfo/announcement/c/2013-12-24/600211_20131225_1.pdf
398,2014-01-01,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2013-12-31/600211_20140101_1.pdf
399,2014-01-16,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2014-01-15/600211_20140116_1.pdf
400,2014-01-16,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2014-01-15/600211_20140116_2.pdf
401,2014-01-22,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2014-01-21/600211_20140122_1.pdf
402,2014-01-28,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2014-01-27/600211_20140128_1.pdf
403,2014-02-11,西藏药业关于2013年度审计会计师事务所更名的公告,/disclosure/listedinfo/announcement/c/2014-02-10/600211_20140211_1.pdf
404,2014-02-12,西藏药业关于公司股票价格异常波动的公告,/disclosure/listedinfo/announcement/c/2014-02-11/600211_20140212_1.pdf
405,2014-02-14,西藏药业关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2014-02-13/600211_20140214_2.pdf
406,2014-02-14,西藏药业澄清公告,/disclosure/listedinfo/announcement/c/2014-02-13/600211_20140214_1.pdf
407,2014-02-14,西藏药业：深圳市康哲药业有限公司及其一致行动人简式权益变动报告书,/disclosure/listedinfo/announcement/c/2014-02-13/600211_20140214_3.pdf
408,2014-02-15,西藏药业关于收到监管部门问询函的公告,/disclosure/listedinfo/announcement/c/2014-02-14/600211_20140215_1.pdf
409,2014-02-18,西藏药业停牌提示性公告,/disclosure/listedinfo/announcement/c/2014-02-17/600211_20140218_1.pdf
410,2014-02-22,西藏药业关于实际控制人发生变动的提示性公告,/disclosure/listedinfo/announcement/c/2014-02-21/600211_20140222_4.pdf
411,2014-02-22,西藏药业关于核查结果的公告,/disclosure/listedinfo/announcement/c/2014-02-21/600211_20140222_3.pdf
412,2014-02-22,西藏药业关于公司股票价格异常波动的公告,/disclosure/listedinfo/announcement/c/2014-02-21/600211_20140222_1.pdf
413,2014-02-22,西藏药业复牌提示性公告,/disclosure/listedinfo/announcement/c/2014-02-21/600211_20140222_2.pdf
414,2014-02-28,西藏药业股东减持股份的提示性公告,/disclosure/listedinfo/announcement/c/2014-02-27/600211_20140228_1.pdf
415,2014-03-04,西藏药业关于股东违规买卖公司股票的公告,/disclosure/listedinfo/announcement/c/2014-03-03/600211_20140304_1.pdf
416,2014-03-06,西藏药业关于控股子公司获得银行授信的公告,/disclosure/listedinfo/announcement/c/2014-03-05/600211_20140306_1.pdf
417,2014-04-16,西藏药业年报摘要,/disclosure/listedinfo/announcement/c/2014-04-15/600211_2013_nzy.pdf
418,2014-04-16,西藏药业年报,/disclosure/listedinfo/announcement/c/2014-04-15/600211_2013_n.pdf
419,2014-04-16,西藏药业累积投票制实施细则,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_15.pdf
420,2014-04-16,西藏药业关于召开2013年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_7.pdf
421,2014-04-16,西藏药业关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_6.pdf
422,2014-04-16,西藏药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_4.pdf
423,2014-04-16,西藏药业关于计提减值准备的公告,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_5.pdf
424,2014-04-16,西藏药业公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_16.pdf
425,2014-04-16,西藏药业独立董事提名人声明,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_9.pdf
426,2014-04-16,西藏药业独立董事候选人声明（张意龙）,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_13.pdf
427,2014-04-16,西藏药业独立董事候选人声明（饶洁）,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_12.pdf
428,2014-04-16,西藏药业独立董事候选人声明（李文兴）,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_11.pdf
429,2014-04-16,西藏药业独立董事候选人声明（李其）,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_10.pdf
430,2014-04-16,西藏药业独立董事2013年度述职报告,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_21.pdf
431,2014-04-16,西藏药业董事会审计委员会实施细则,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_14.pdf
432,2014-04-16,西藏药业董事会审计委员会2013年度履职情况报告,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_23.pdf
433,2014-04-16,西藏药业第四届监事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_3.pdf
434,2014-04-16,西藏药业第四届董事会第二十次会议决议公告,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_2.pdf
435,2014-04-16,西藏药业：国都证券有限责任公司关于西藏诺迪康药业股份有限公司股权分置改革2013年年度保荐工作报告书,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_24.pdf
436,2014-04-16,西藏药业：关于公司对外担保的专项说明及独立董事意见,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_18.pdf
437,2014-04-16,西藏药业2013年度审计报告,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_19.pdf
438,2014-04-16,西藏药业2013年度控股股东及其他关联方资金占用情况的专项说明,/disclosure/listedinfo/announcement/c/2014-04-15/600211_20140416_20.pdf
439,2014-04-25,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-24/600211_2014_1.pdf
440,2014-04-29,西藏药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2014-04-28/600211_20140429_1.pdf
441,2014-04-29,西藏药业关于2013年度股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2014-04-28/600211_20140429_2.pdf
442,2014-04-29,西藏药业独立董事关于新活素独家代理相关协议的独立意见,/disclosure/listedinfo/announcement/c/2014-04-28/600211_20140429_3.pdf
443,2014-04-29,西藏药业2013年年度股东大会文件,/disclosure/listedinfo/announcement/c/2014-04-30/600211_20140429_4.pdf
444,2014-05-09,西藏药业第五届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-05-08/600211_20140509_2.pdf
445,2014-05-09,西藏药业2013年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-05-08/600211_20140509_1.pdf
446,2014-05-09,西藏药业2013年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-05-08/600211_20140509_3.pdf
447,2014-05-10,西藏药业第五届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2014-05-09/600211_20140510_1.pdf
448,2014-05-10,西藏药业2013年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-05-09/600211_20140510_2.pdf
449,2014-05-22,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2014-05-21/600211_20140522_1.pdf
450,2014-05-23,西藏药业关于收到监管部门问询函的公告,/disclosure/listedinfo/announcement/c/2014-05-22/600211_20140523_1.pdf
451,2014-05-24,西藏药业关于股东减持股份的提示性公告,/disclosure/listedinfo/announcement/c/2014-05-23/600211_20140524_1.pdf
452,2014-05-27,西藏药业关于法定代表人变更的公告,/disclosure/listedinfo/announcement/c/2014-05-26/600211_20140527_1.pdf
453,2014-06-21,西藏药业2013年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2014-06-20/600211_20140621_1.pdf
454,2014-06-27,西藏药业关于收到监管部门函件的公告,/disclosure/listedinfo/announcement/c/2014-06-26/600211_20140627_1.pdf
455,2014-07-05,西藏药业关于召开2014年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-07-04/600211_20140705_2.pdf
456,2014-07-05,西藏药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2014-07-04/600211_20140705_3.pdf
457,2014-07-05,西藏药业关于聘任财务总监、总工程师的独立意见,/disclosure/listedinfo/announcement/c/2014-07-04/600211_20140705_6.pdf
458,2014-07-05,西藏药业关于公司及相关主体承诺履行情况的专项公告,/disclosure/listedinfo/announcement/c/2014-07-04/600211_20140705_4.pdf
459,2014-07-05,西藏药业股东大会议事规则,/disclosure/listedinfo/announcement/c/2014-07-04/600211_20140705_7.pdf
460,2014-07-05,西藏药业公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-07-04/600211_20140705_9.pdf
461,2014-07-05,西藏药业独立董事关于公司董事、监事津贴的独立意见,/disclosure/listedinfo/announcement/c/2014-07-04/600211_20140705_5.pdf
462,2014-07-05,西藏药业董事会议事规则,/disclosure/listedinfo/announcement/c/2014-07-04/600211_20140705_8.pdf
463,2014-07-05,西藏药业第五届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2014-07-04/600211_20140705_1.pdf
464,2014-07-24,西藏药业2014年第一次临时股东大会文件,/disclosure/listedinfo/announcement/c/2014-07-23/600211_20140724_1.pdf
465,2014-07-25,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2014-07-24/600211_20140725_1.pdf
466,2014-07-31,西藏药业2014年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-07-30/600211_20140731_1.pdf
467,2014-07-31,西藏药业2014年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-07-30/600211_20140731_2.pdf
468,2014-08-09,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2014-08-08/600211_20140809_1.pdf
469,2014-08-15,西藏药业重大资产重组停牌公告,/disclosure/listedinfo/announcement/c/2014-08-14/600211_20140815_1.pdf
470,2014-08-16,西藏药业重大事项内部报告制度,/disclosure/listedinfo/announcement/c/2014-08-15/600211_20140816_3.pdf
471,2014-08-16,西藏药业关于第五届董事会第三次会议决议的补充说明,/disclosure/listedinfo/announcement/c/2014-08-15/600211_20140816_6.pdf
472,2014-08-16,西藏药业第五届董事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-15/600211_20140816_1.pdf
473,2014-08-16,西藏药业半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-15/600211_2014_zzy.pdf
474,2014-08-16,西藏药业半年报,/disclosure/listedinfo/announcement/c/2014-08-15/600211_2014_z.pdf
475,2014-08-22,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-08-21/600211_20140822_1.pdf
476,2014-08-22,西藏药业关于收到大股东函件的公告,/disclosure/listedinfo/announcement/c/2014-08-21/600211_20140822_2.pdf
477,2014-08-29,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-08-28/600211_20140829_1.pdf
478,2014-08-30,西藏药业第五届董事会第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2014-08-29/600211_20140830_1.pdf
479,2014-09-05,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-09-04/600211_20140905_1.pdf
480,2014-09-11,西藏药业监事会召开2014年第三次临时股东大会通知的公告,/disclosure/listedinfo/announcement/c/2014-09-10/600211_20140911_3.pdf
481,2014-09-11,西藏药业监事会召开2014年第二次临时股东大会通知的公告,/disclosure/listedinfo/announcement/c/2014-09-10/600211_20140911_2.pdf
482,2014-09-11,西藏药业独立董事提名人声明（吕先锫）,/disclosure/listedinfo/announcement/c/2014-09-10/600211_20140911_6.pdf
483,2014-09-11,西藏药业独立董事提名人声明（刘小进）,/disclosure/listedinfo/announcement/c/2014-09-10/600211_20140911_5.pdf
484,2014-09-11,西藏药业独立董事候选人声明（吕先锫）,/disclosure/listedinfo/announcement/c/2014-09-10/600211_20140911_8.pdf
485,2014-09-11,西藏药业独立董事候选人声明（刘小进）,/disclosure/listedinfo/announcement/c/2014-09-10/600211_20140911_7.pdf
486,2014-09-11,西藏药业第五届监事会第三次会议决议公告,/disclosure/listedinfo/announcement/c/2014-09-10/600211_20140911_1.pdf
487,2014-09-11,西藏药业：北京中伦(成都)律师事务所关于西藏诺迪康药业股份有限公司监事会根据股东提议召集公司临时股东大会有关事宜的法律意见书,/disclosure/listedinfo/announcement/c/2014-09-10/600211_20140911_4.pdf
488,2014-09-12,西藏药业重大资产重组延长停牌期的公告,/disclosure/listedinfo/announcement/c/2014-09-11/600211_20140912_1.pdf
489,2014-09-13,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2014-09-12/600211_20140913_3.pdf
490,2014-09-13,西藏药业关于收到监事函件的公告,/disclosure/listedinfo/announcement/c/2014-09-12/600211_20140913_1.pdf
491,2014-09-13,西藏药业关于收到大股东函件的公告,/disclosure/listedinfo/announcement/c/2014-09-12/600211_20140913_2.pdf
492,2014-09-17,西藏药业重大事项进展公告,/disclosure/listedinfo/announcement/c/2014-09-16/600211_20140917_3.pdf
493,2014-09-17,西藏药业关于收到监事会函件的公告,/disclosure/listedinfo/announcement/c/2014-09-16/600211_20140917_1.pdf
494,2014-09-17,西藏药业关于收到大股东函件的公告,/disclosure/listedinfo/announcement/c/2014-09-16/600211_20140917_2.pdf
495,2014-09-18,西藏药业关于上海证券交易所《监管工作函》涉及有关问题的公告,/disclosure/listedinfo/announcement/c/2014-09-17/600211_20140918_1.pdf
496,2014-09-19,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-09-18/600211_20140919_2.pdf
497,2014-09-19,西藏药业2014年第二次临时股东大会文件,/disclosure/listedinfo/announcement/c/2014-09-18/600211_20140919_1.pdf
498,2014-09-20,西藏药业关于2014年第三次临时股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2014-09-19/600211_20140920_3.pdf
499,2014-09-20,西藏药业更正公告,/disclosure/listedinfo/announcement/c/2014-09-19/600211_20140920_2.pdf
500,2014-09-20,西藏药业独立董事提名人声明（张玉周）,/disclosure/listedinfo/announcement/c/2014-09-19/600211_20140920_5.pdf
501,2014-09-20,西藏药业独立董事候选人声明（张玉周）,/disclosure/listedinfo/announcement/c/2014-09-19/600211_20140920_4.pdf
502,2014-09-20,西藏药业第五届董事会第二次临时会议决议公告,/disclosure/listedinfo/announcement/c/2014-09-19/600211_20140920_1.pdf
503,2014-09-23,西藏药业涉及诉讼公告,/disclosure/listedinfo/announcement/c/2014-09-22/600211_20140923_3.pdf
504,2014-09-23,西藏药业监事会关于2014年第三次临时股东大会增加临时提案的补充说明,/disclosure/listedinfo/announcement/c/2014-09-22/600211_20140923_2.pdf
505,2014-09-23,西藏药业关于2014年第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2014-09-22/600211_20140923_4.pdf
506,2014-09-23,西藏药业2014年第三次临时股东大会文件,/disclosure/listedinfo/announcement/c/2014-09-22/600211_20140923_1.pdf
507,2014-09-24,西藏药业关于收到独立董事函件的公告,/disclosure/listedinfo/announcement/c/2014-09-23/600211_20140924_1.pdf
508,2014-09-25,西藏药业关于收到大股东函件的公告,/disclosure/listedinfo/announcement/c/2014-09-24/600211_20140925_1.pdf
509,2014-09-26,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2014-09-25/600211_20140926_1.pdf
510,2014-09-27,西藏药业关于收到监事函件的公告,/disclosure/listedinfo/announcement/c/2014-09-26/600211_20140927_4.pdf
511,2014-09-27,西藏药业关于收到大股东函件的公告,/disclosure/listedinfo/announcement/c/2014-09-26/600211_20140927_1.pdf
512,2014-09-27,西藏药业关于2014年第三次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2014-09-26/600211_20140927_3.pdf
513,2014-09-27,西藏药业2014年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-09-26/600211_20140927_2.pdf
514,2014-09-27,西藏药业2014年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-09-26/600211_20140927_5.pdf
515,2014-10-01,西藏药业关于收到大股东函件的公告,/disclosure/listedinfo/announcement/c/2014-09-30/600211_20141001_2.pdf
516,2014-10-01,西藏药业2014年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-09-30/600211_20141001_1.pdf
517,2014-10-01,西藏药业2014年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-09-30/600211_20141001_3.pdf
518,2014-10-09,西藏药业终止本次重大资产重组暨复牌公告,/disclosure/listedinfo/announcement/c/2014-10-08/600211_20141009_1.pdf
519,2014-10-11,西藏药业停牌提示性公告,/disclosure/listedinfo/announcement/c/2014-10-10/600211_20141011_1.pdf
520,2014-10-17,西藏药业关于大股东持有股份被继续冻结的公告,/disclosure/listedinfo/announcement/c/2014-10-16/600211_20141017_1.pdf
521,2014-10-22,西藏药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2014-10-21/600211_20141022_2.pdf
522,2014-10-22,西藏药业关于股价异常波动核查结果公告,/disclosure/listedinfo/announcement/c/2014-10-21/600211_20141022_1.pdf
523,2014-10-23,西藏药业更正公告,/disclosure/listedinfo/announcement/c/2014-10-22/600211_20141023_1.pdf
524,2014-10-29,西藏药业重大事项进展暨继续停牌公告,/disclosure/listedinfo/announcement/c/2014-10-28/600211_20141029_1.pdf
525,2014-10-30,西藏药业详式权益变动报告书（深圳市康哲医药科技开发有限公司）,/disclosure/listedinfo/announcement/c/2014-10-29/600211_20141030_1.pdf
526,2014-10-30,西藏药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2014-10-29/600211_20141030_4.pdf
527,2014-10-30,西藏药业关于股东权益变动及公司控股股东和实际控制人发生变更的提示性公告,/disclosure/listedinfo/announcement/c/2014-10-29/600211_20141030_2.pdf
528,2014-10-30,西藏药业复牌提示性公告,/disclosure/listedinfo/announcement/c/2014-10-29/600211_20141030_3.pdf
529,2014-10-30,西藏药业：宏源证券股份有限公司关于西藏诺迪康药业股份有限公司详式权益变动报告书之财务顾问核查意见,/disclosure/listedinfo/announcement/c/2014-10-29/600211_20141030_5.pdf
530,2014-10-31,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-30/600211_2014_3.pdf
531,2014-11-04,西藏药业关于公司股票价格异常波动的公告,/disclosure/listedinfo/announcement/c/2014-11-03/600211_20141104_1.pdf
532,2014-11-06,西藏药业关于大股东持有股份被解除质押的公告,/disclosure/listedinfo/announcement/c/2014-11-05/600211_20141106_1.pdf
533,2014-11-12,西藏药业股东股权过户完成公告,/disclosure/listedinfo/announcement/c/2014-11-11/600211_20141112_1.pdf
534,2014-11-22,西藏药业第五届董事会第四次临时会议决议公告,/disclosure/listedinfo/announcement/c/2014-11-21/600211_20141122_1.pdf
535,2014-12-09,西藏药业涉及诉讼进展公告,/disclosure/listedinfo/announcement/c/2014-12-08/600211_20141209_1.pdf
536,2014-12-16,西藏药业涉及诉讼进展公告,/disclosure/listedinfo/announcement/c/2014-12-15/600211_20141216_1.pdf
537,2014-12-17,西藏药业关于董事长等三位董事辞职的公告,/disclosure/listedinfo/announcement/c/2014-12-16/600211_20141217_1.pdf
538,2014-12-23,西藏药业关于召开2015年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-12-22/600211_20141223_2.pdf
539,2014-12-23,西藏药业独立董事关于提名董事候选人的独立意见,/disclosure/listedinfo/announcement/c/2014-12-22/600211_20141223_3.pdf
540,2014-12-23,西藏药业第五届董事会第五次临时会议决议公告,/disclosure/listedinfo/announcement/c/2014-12-22/600211_20141223_1.pdf
541,2014-12-31,西藏药业2015年第一次临时股东大会文件,/disclosure/listedinfo/announcement/c/2014-12-30/600211_20141231_1.pdf
542,2015-01-09,西藏药业第五届董事会第六次临时会议决议公告,/disclosure/listedinfo/announcement/c/2015-01-08/600211_20150109_2.pdf
543,2015-01-09,西藏药业2015年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-01-08/600211_20150109_1.pdf
544,2015-01-09,西藏药业2015年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-01-08/600211_20150109_3.pdf
545,2015-01-15,西藏药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2015-01-14/600211_20150115_1.pdf
546,2015-01-15,西藏药业关于召开2015年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-01-14/600211_20150115_3.pdf
547,2015-01-15,西藏药业关于吸收合并下属全资子公司的公告,/disclosure/listedinfo/announcement/c/2015-01-14/600211_20150115_2.pdf
548,2015-01-15,西藏药业独立董事关于诺迪康独家代理相关协议的独立意见,/disclosure/listedinfo/announcement/c/2015-01-14/600211_20150115_4.pdf
549,2015-01-22,西藏药业日常关联交易补充公告,/disclosure/listedinfo/announcement/c/2015-01-21/600211_20150122_3.pdf
550,2015-01-22,西藏药业关于吸收合并下属全资子公司的补充公告,/disclosure/listedinfo/announcement/c/2015-01-21/600211_20150122_2.pdf
551,2015-01-22,西藏药业补充公告,/disclosure/listedinfo/announcement/c/2015-01-21/600211_20150122_1.pdf
552,2015-01-27,西藏药业重大事项公告,/disclosure/listedinfo/announcement/c/2015-01-27/600211_20150127_3.pdf
553,2015-01-27,西藏药业关于2015年第二次临时股东大会补充公告,/disclosure/listedinfo/announcement/c/2015-01-27/600211_20150127_2.pdf
554,2015-01-27,西藏药业2015年第二次临时股东大会文件,/disclosure/listedinfo/announcement/c/2015-01-27/600211_20150127_1.pdf
555,2015-01-31,西藏药业：国都证券有限责任公司关于西藏诺迪康药业股份有限公司股权分置改革2014年年度保荐工作报告书,/disclosure/listedinfo/announcement/c/2015-01-30/600211_20150131_1.pdf
556,2015-02-03,西藏药业2015年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-02-02/600211_20150203_1.pdf
557,2015-02-03,西藏药业2015年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-02-02/600211_20150203_2.pdf
558,2015-02-06,西藏药业更正公告,/disclosure/listedinfo/announcement/c/2015-02-05/600211_20150206_1.pdf
559,2015-02-06,西藏药业：四川良禾律师事务所关于《四川良禾律师事务所关于西藏诺迪康药业股份有限公司2015年第二次临时股东大会的法律意见书》的更正说明,/disclosure/listedinfo/announcement/c/2015-02-05/600211_20150206_2.pdf
560,2015-02-14,西藏药业重大事项进展公告,/disclosure/listedinfo/announcement/c/2015-02-13/600211_20150214_1.pdf
561,2015-03-13,西藏药业关于全资子公司获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2015-03-12/600211_20150313_1.pdf
562,2015-03-26,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_6.pdf
563,2015-03-26,西藏药业年报摘要,/disclosure/listedinfo/announcement/c/2015-03-25/600211_2014_nzy.pdf
564,2015-03-26,西藏药业年报,/disclosure/listedinfo/announcement/c/2015-03-25/600211_2014_n.pdf
565,2015-03-26,西藏药业监事会议事规则,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_11.pdf
566,2015-03-26,西藏药业监事会关于会计政策变更的说明,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_21.pdf
567,2015-03-26,西藏药业监事会对非标准无保留内控审计意见涉及事项的说明,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_25.pdf
568,2015-03-26,西藏药业关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_8.pdf
569,2015-03-26,西藏药业关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_4.pdf
570,2015-03-26,西藏药业关于停止西藏药业医药创新园区一期开发项目的公告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_5.pdf
571,2015-03-26,西藏药业关于日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_2.pdf
572,2015-03-26,西藏药业关于计提减值准备的公告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_3.pdf
573,2015-03-26,西藏药业独立董事关于新活素日常关联交易预计的独立意见,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_10.pdf
574,2015-03-26,西藏药业独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_13.pdf
575,2015-03-26,西藏药业独立董事对非标准无保留内控审计意见涉及事项的说明,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_20.pdf
576,2015-03-26,西藏药业独立董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_16.pdf
577,2015-03-26,西藏药业董事会审计委员会2014年度履职情况报告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_26.pdf
578,2015-03-26,西藏药业董事会关于会计政策变更的说明,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_19.pdf
579,2015-03-26,西藏药业董事会对非标准无保留内控审计意见涉及事项的说明,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_18.pdf
580,2015-03-26,西藏药业第五届监事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_7.pdf
581,2015-03-26,西藏药业第五届董事会第四次会议决议公告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_1.pdf
582,2015-03-26,西藏药业财务报表附注,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_27.pdf
583,2015-03-26,西藏药业：关于西藏诺迪康药业股份有限公司2014年内部控制审计非标意见的专项说明,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_22.pdf
584,2015-03-26,西藏药业：关于西藏诺迪康药业股份有限公司2014年度控股股东及其他关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_15.pdf
585,2015-03-26,西藏药业2014年内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_24.pdf
586,2015-03-26,西藏药业2014年度年报审计报告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_14.pdf
587,2015-03-26,西藏药业2014年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_17.pdf
588,2015-03-26,西藏药业2014年度会计政策或会计估计变更的专项说明,/disclosure/listedinfo/announcement/c/2015-03-25/600211_20150326_23.pdf
589,2015-03-28,西藏药业关于2014年年度股东大会更正补充公告,/disclosure/listedinfo/announcement/c/2015-03-27/600211_20150328_1.pdf
590,2015-04-09,西藏药业关于召开2014年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-04-08/600211_20150409_1.pdf
591,2015-04-09,西藏药业关于法定代表人变更的公告,/disclosure/listedinfo/announcement/c/2015-04-08/600211_20150409_2.pdf
592,2015-04-09,西藏药业2014年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-04-08/600211_20150409_3.pdf
593,2015-04-17,西藏药业2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-04-16/600211_20150417_1.pdf
594,2015-04-17,西藏药业2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-04-16/600211_20150417_2.pdf
595,2015-04-24,西藏药业关于经营范围变更的公告,/disclosure/listedinfo/announcement/c/2015-04-23/600211_20150424_1.pdf
596,2015-04-25,西藏药业第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-24/600211_2015_1.pdf
597,2015-05-01,西藏药业关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2015-04-30/600211_20150501_1.pdf
598,2015-05-20,西藏药业简式权益变动报告书,/disclosure/listedinfo/announcement/c/2015-05-19/600211_20150520_2.pdf
599,2015-05-20,西藏药业关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2015-05-19/600211_20150520_1.pdf
600,2015-05-22,西藏药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2015-05-21/600211_20150522_1.pdf
601,2015-05-26,西藏药业2014年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2015-05-25/600211_20150526_1.pdf
602,2015-05-29,西藏药业重大事项继续停牌公告,/disclosure/listedinfo/announcement/c/2015-05-28/600211_20150529_1.pdf
603,2015-06-05,西藏药业重大资产重组停牌公告,/disclosure/listedinfo/announcement/c/2015-06-04/600211_20150605_1.pdf
604,2015-06-11,西藏药业年报摘要（修订稿）,/disclosure/listedinfo/announcement/c/2015-06-10/600211_2014_nzy.pdf
605,2015-06-11,西藏药业年报（修订版）,/disclosure/listedinfo/announcement/c/2015-06-10/600211_2014_n.pdf
606,2015-06-11,西藏药业关于对2014年年报事后审核意见的回复及更正公告,/disclosure/listedinfo/announcement/c/2015-06-10/600211_20150611_1.pdf
607,2015-06-11,西藏药业：关于西藏诺迪康药业股份有限公司2014年年报相关财务会计信息的专项核查说明,/disclosure/listedinfo/announcement/c/2015-06-10/600211_20150611_4.pdf
608,2015-06-12,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-06-11/600211_20150612_1.pdf
609,2015-06-19,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-06-18/600211_20150619_1.pdf
610,2015-06-27,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-06-26/600211_20150627_1.pdf
611,2015-07-04,西藏药业重大资产重组继续停牌公告,/disclosure/listedinfo/announcement/c/2015-07-03/600211_20150704_1.pdf
612,2015-07-09,西藏药业关于大股东承诺不减持股份的公告,/disclosure/listedinfo/announcement/c/2015-07-08/600211_20150709_1.pdf
613,2015-07-10,西藏药业关于维护公司股价稳定的公告,/disclosure/listedinfo/announcement/c/2015-07-09/600211_20150710_1.pdf
614,2015-07-11,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-07-10/600211_20150711_1.pdf
615,2015-07-18,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-07-17/600211_20150718_1.pdf
616,2015-07-23,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2015-07-22/600211_20150723_2.pdf
617,2015-07-23,西藏药业关于董事、监事辞职的公告,/disclosure/listedinfo/announcement/c/2015-07-22/600211_20150723_1.pdf
618,2015-07-25,西藏药业重大资产重组进展公告,/disclosure/listedinfo/announcement/c/2015-07-24/600211_20150725_1.pdf
619,2015-07-29,西藏药业重大资产重组进展暨继续停牌公告,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_17.pdf
620,2015-07-29,西藏药业重大资产出售报告书（草案）摘要,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_6.pdf
621,2015-07-29,西藏药业重大资产出售报告书（草案）,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_10.pdf
622,2015-07-29,西藏药业日常关联交易公告,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_3.pdf
623,2015-07-29,西藏药业拟转让四川本草堂药业有限公司51%股权项目资产评估报告,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_13.pdf
624,2015-07-29,西藏药业关于召开2015年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_5.pdf
625,2015-07-29,西藏药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_2.pdf
626,2015-07-29,西藏药业公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_8.pdf
627,2015-07-29,西藏药业独立董事关于提名董事候选人的独立意见,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_7.pdf
628,2015-07-29,西藏药业独立董事关于签订新活素、诺迪康推广服务协议之补充协议的独立意见,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_9.pdf
629,2015-07-29,西藏药业独立董事关于公司重大资产重组的独立意见,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_15.pdf
630,2015-07-29,西藏药业第五届监事会第七次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_4.pdf
631,2015-07-29,西藏药业第五届董事会第六次会议决议公告,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_1.pdf
632,2015-07-29,西藏药业：四川本草堂药业有限公司2013年度、2014年度和2015年1-5月审计报告,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_12.pdf
633,2015-07-29,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司重大资产出售之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_11.pdf
634,2015-07-29,西藏药业：关于西藏诺迪康药业股份有限公司重大资产出售的法律意见书,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_14.pdf
635,2015-07-29,西藏药业2013年、2014年度和2015年1-5月备考财务报表审阅报告,/disclosure/listedinfo/announcement/c/2015-07-28/600211_20150729_16.pdf
636,2015-08-01,西藏药业关于2015年第三次临时股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2015-08-01/600211_20150801_1.pdf
637,2015-08-07,西藏药业关于收到上海证券交易所审核意见函的公告,/disclosure/listedinfo/announcement/c/2015-08-07/600211_20150807_1.pdf
638,2015-08-08,西藏药业关于召开2015年第三次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-08-08/600211_20150808_1.pdf
639,2015-08-11,西藏药业重大资产出售报告书（草案）摘要修订稿,/disclosure/listedinfo/announcement/c/2015-08-11/600211_20150811_4.pdf
640,2015-08-11,西藏药业重大资产出售报告书（草案）修订稿,/disclosure/listedinfo/announcement/c/2015-08-11/600211_20150811_5.pdf
641,2015-08-11,西藏药业关于对上海证券交易所审核意见函的回复,/disclosure/listedinfo/announcement/c/2015-08-11/600211_20150811_2.pdf
642,2015-08-11,西藏药业复牌提示性公告,/disclosure/listedinfo/announcement/c/2015-08-11/600211_20150811_3.pdf
643,2015-08-11,西藏药业：泰和泰律师事务所关于《上海证券交易所关于对西藏诺迪康药业股份有限公司重大资产出售报告书（草案）的审核意见函》的回复,/disclosure/listedinfo/announcement/c/2015-08-11/600211_20150811_7.pdf
644,2015-08-11,西藏药业：四川华信（集团）会计师事务所（特殊普通合伙）关于上海证券交易所《关于西藏诺迪康药业股份有限公司重大资产出售报告书（草案）的审核意见函》相关问题的核查意见,/disclosure/listedinfo/announcement/c/2015-08-11/600211_20150811_9.pdf
645,2015-08-11,西藏药业：申万宏源证券承销保荐有限责任公司关于上海证券交易所《关于对西藏诺迪康药业股份有限公司重大资产出售报告书（草案）的审核意见函》相关问题的核查意见,/disclosure/listedinfo/announcement/c/2015-08-11/600211_20150811_6.pdf
646,2015-08-11,西藏药业：北京北方亚事资产评估有限责任公司关于上海证券交易所《关于对西藏诺迪康药业股份有限公司重大资产出售报告书（草案）的审核意见函》的回复意见,/disclosure/listedinfo/announcement/c/2015-08-11/600211_20150811_8.pdf
647,2015-08-11,西藏药业2015年第三次临时股东大会文件,/disclosure/listedinfo/announcement/c/2015-08-11/600211_20150811_1.pdf
648,2015-08-12,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2015-08-12/600211_20150812_1.pdf
649,2015-08-13,西藏药业半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-13/600211_2015_zzy.pdf
650,2015-08-13,西藏药业半年报,/disclosure/listedinfo/announcement/c/2015-08-13/600211_2015_z.pdf
651,2015-08-14,西藏药业关于公司股票价格异常波动的公告,/disclosure/listedinfo/announcement/c/2015-08-14/600211_20150814_2.pdf
652,2015-08-14,西藏药业：关于西藏药业股票交易异常波动涉及相关问题问询函的回函,/disclosure/listedinfo/announcement/c/2015-08-14/600211_20150814_4.pdf
653,2015-08-14,西藏药业2015年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-08-14/600211_20150814_1.pdf
654,2015-08-14,西藏药业2015年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-08-14/600211_20150814_3.pdf
655,2015-08-25,西藏药业重大资产出售报告书（草案）第二次修订稿,/disclosure/listedinfo/announcement/c/2015-08-25/600211_20150825_2.pdf
656,2015-08-25,西藏药业更正公告,/disclosure/listedinfo/announcement/c/2015-08-25/600211_20150825_1.pdf
657,2015-08-29,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2015-08-29/600211_20150829_1.pdf
658,2015-09-01,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2015-09-01/600211_20150901_1.pdf
659,2015-09-03,西藏药业重大资产出售实施情况报告书,/disclosure/listedinfo/announcement/c/2015-09-03/600211_20150903_1.pdf
660,2015-09-03,西藏药业关于公司股票价格异常波动的公告,/disclosure/listedinfo/announcement/c/2015-09-03/600211_20150903_2.pdf
661,2015-09-03,西藏药业：泰和泰律师事务所关于西藏诺迪康药业股份有限公司重大资产出售之交易实施情况的法律意见书,/disclosure/listedinfo/announcement/c/2015-09-03/600211_20150903_4.pdf
662,2015-09-03,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司重大资产出售实施情况之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2015-09-03/600211_20150903_3.pdf
663,2015-09-03,西藏药业：关于西藏药业股票交易异常波动涉及相关问题问询函的回函,/disclosure/listedinfo/announcement/c/2015-09-03/600211_20150903_5.pdf
664,2015-10-01,西藏药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2015-10-01/600211_20151001_1.pdf
665,2015-10-01,西藏药业关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2015-10-01/600211_20151001_2.pdf
666,2015-10-15,西藏药业重大事项继续停牌公告,/disclosure/listedinfo/announcement/c/2015-10-15/600211_20151015_1.pdf
667,2015-10-22,西藏药业重大资产重组停牌公告,/disclosure/listedinfo/announcement/c/2015-10-22/600211_20151022_1.pdf
668,2015-10-28,西藏药业终止重大资产重组公告,/disclosure/listedinfo/announcement/c/2015-10-28/600211_20151028_3.pdf
669,2015-10-28,西藏药业复牌提示性公告,/disclosure/listedinfo/announcement/c/2015-10-28/600211_20151028_4.pdf
670,2015-10-28,西藏药业第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-28/600211_2015_3.pdf
671,2015-11-18,西藏药业关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2015-11-18/600211_20151118_1.pdf
672,2015-11-25,西藏药业第五届董事会第九次临时会议决议公告,/disclosure/listedinfo/announcement/c/2015-11-25/600211_20151125_1.pdf
673,2015-12-17,西藏药业关于获得《药品经营质量管理规范认证证书》的公告,/disclosure/listedinfo/announcement/c/2015-12-17/600211_20151217_1.pdf
674,2015-12-19,西藏药业关于下属子公司获得《高新技术企业证书》的公告,/disclosure/listedinfo/announcement/c/2015-12-19/600211_20151219_1.pdf
675,2015-12-31,西藏药业关于获得《药品GMP证书》的公告,/disclosure/listedinfo/announcement/c/2015-12-31/600211_20151231_1.pdf
676,2015-12-31,西藏药业关于独立董事辞职的公告,/disclosure/listedinfo/announcement/c/2015-12-31/600211_20151231_2.pdf
677,2016-01-01,西藏药业关于获得《药品GMP证书》的补充公告,/disclosure/listedinfo/announcement/c/2016-01-01/600211_20160101_1.pdf
678,2016-01-12,西藏药业第五届董事会第十次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-01-12/600211_20160112_1.pdf
679,2016-01-28,西藏药业2015年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2016-01-28/600211_20160128_1.pdf
680,2016-02-18,西藏药业对外投资公告,/disclosure/listedinfo/announcement/c/2016-02-18/600211_20160218_1.pdf
681,2016-02-20,西藏药业重大事项停牌公告,/disclosure/listedinfo/announcement/c/2016-02-20/600211_20160220_1.pdf
682,2016-02-27,西藏药业重大事项继续停牌公告,/disclosure/listedinfo/announcement/c/2016-02-27/600211_20160227_1.pdf
683,2016-03-01,西藏药业重大资产重组停牌公告,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_14.pdf
684,2016-03-01,西藏药业收购资产暨关联交易的公告,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_4.pdf
685,2016-03-01,西藏药业审计委员会对收购资产涉及关联交易的审核意见,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_13.pdf
686,2016-03-01,西藏药业审计委员会对非公开发行股票涉及关联交易的审核意见,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_10.pdf
687,2016-03-01,西藏药业关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_5.pdf
688,2016-03-01,西藏药业非公开发行股票暨关联交易的公告,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_3.pdf
689,2016-03-01,西藏药业非公开发行A股股票募集资金运用的可行性分析报告,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_7.pdf
690,2016-03-01,西藏药业独立董事关于公司拟收购依姆多相关资产及相关关联交易的议案的事前认可声明,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_11.pdf
691,2016-03-01,西藏药业独立董事关于公司拟收购依姆多相关资产及相关关联交易的独立意见,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_12.pdf
692,2016-03-01,西藏药业独立董事关于公司非公开发行A股股票涉及关联交易的事前认可声明,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_8.pdf
693,2016-03-01,西藏药业独立董事关于公司非公开发行A股股票涉及关联交易的独立意见,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_9.pdf
694,2016-03-01,西藏药业第五届监事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_2.pdf
695,2016-03-01,西藏药业第五届董事会第十一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_1.pdf
696,2016-03-01,西藏药业2016年度非公开发行股票预案,/disclosure/listedinfo/announcement/c/2016-03-01/600211_20160301_6.pdf
697,2016-03-02,西藏药业关于与特定对象签署附条件生效的非公开发行股票之认购协议的公告,/disclosure/listedinfo/announcement/c/2016-03-02/600211_20160302_1.pdf
698,2016-03-04,西藏药业收购报告书摘要,/disclosure/listedinfo/announcement/c/2016-03-04/600211_20160304_1.pdf
699,2016-03-08,西藏药业重大资产重组进展暨继续停牌公告,/disclosure/listedinfo/announcement/c/2016-03-08/600211_20160308_3.pdf
700,2016-03-08,西藏药业重大资产购买预案（摘要）,/disclosure/listedinfo/announcement/c/2016-03-08/600211_20160308_4.pdf
701,2016-03-08,西藏药业重大资产购买预案,/disclosure/listedinfo/announcement/c/2016-03-08/600211_20160308_5.pdf
702,2016-03-08,西藏药业审计委员会审核意见,/disclosure/listedinfo/announcement/c/2016-03-08/600211_20160308_9.pdf
703,2016-03-08,西藏药业独立董事意见,/disclosure/listedinfo/announcement/c/2016-03-08/600211_20160308_6.pdf
704,2016-03-08,西藏药业独立董事事前认可声明,/disclosure/listedinfo/announcement/c/2016-03-08/600211_20160308_8.pdf
705,2016-03-08,西藏药业第五届监事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-08/600211_20160308_2.pdf
706,2016-03-08,西藏药业第五届董事会第十二次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-08/600211_20160308_1.pdf
707,2016-03-08,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司重大资产购买预案之独立财务顾问核查意见,/disclosure/listedinfo/announcement/c/2016-03-08/600211_20160308_7.pdf
708,2016-03-12,西藏药业关于收到上海证券交易所问询函的公告,/disclosure/listedinfo/announcement/c/2016-03-12/600211_20160312_1.pdf
709,2016-03-16,西藏药业重大资产购买预案（修订稿）（摘要）,/disclosure/listedinfo/announcement/c/2016-03-16/600211_20160316_6.pdf
710,2016-03-16,西藏药业重大资产购买预案（修订稿）,/disclosure/listedinfo/announcement/c/2016-03-16/600211_20160316_7.pdf
711,2016-03-16,西藏药业审计委员会审核意见,/disclosure/listedinfo/announcement/c/2016-03-16/600211_20160316_5.pdf
712,2016-03-16,西藏药业关于收购资产签署《补充协议》暨关联交易的公告,/disclosure/listedinfo/announcement/c/2016-03-16/600211_20160316_1.pdf
713,2016-03-16,西藏药业关于对上海证券交易所问询函的回复,/disclosure/listedinfo/announcement/c/2016-03-16/600211_20160316_2.pdf
714,2016-03-16,西藏药业复牌提示性公告,/disclosure/listedinfo/announcement/c/2016-03-16/600211_20160316_11.pdf
715,2016-03-16,西藏药业独立董事意见,/disclosure/listedinfo/announcement/c/2016-03-16/600211_20160316_4.pdf
716,2016-03-16,西藏药业独立董事事前认可声明,/disclosure/listedinfo/announcement/c/2016-03-16/600211_20160316_3.pdf
717,2016-03-16,西藏药业：申万宏源证券承销保荐有限责任公司关于上海证券交易所《关于对西藏诺迪康药业股份有限公司重大资产购买预案信息披露的问询函》相关问题的核查意见,/disclosure/listedinfo/announcement/c/2016-03-16/600211_20160316_9.pdf
718,2016-03-16,西藏药业：北京市中伦（深圳）律师事务所关于上海证券交易所《关于对西藏诺迪康药业股份有限公司重大资产购买预案信息披露的问询函》的专项回复意见,/disclosure/listedinfo/announcement/c/2016-03-16/600211_20160316_10.pdf
719,2016-03-16,西藏药业2016年度非公开发行股票预案（修订稿）,/disclosure/listedinfo/announcement/c/2016-03-16/600211_20160316_8.pdf
720,2016-03-19,西藏药业投资理财管理制度,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_8.pdf
721,2016-03-19,西藏药业审计委员会对公司日常关联交易的审核意见,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_11.pdf
722,2016-03-19,西藏药业年报摘要,/disclosure/listedinfo/announcement/c/2016-03-19/600211_2015_nzy.pdf
723,2016-03-19,西藏药业年报,/disclosure/listedinfo/announcement/c/2016-03-19/600211_2015_n.pdf
724,2016-03-19,西藏药业关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_6.pdf
725,2016-03-19,西藏药业关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_1.pdf
726,2016-03-19,西藏药业关于日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_4.pdf
727,2016-03-19,西藏药业关于利用闲置资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_3.pdf
728,2016-03-19,西藏药业独立董事关于公司日常关联交易预计的事前认可的声明,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_9.pdf
729,2016-03-19,西藏药业独立董事对2015年年报及相关事项的独董意见,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_10.pdf
730,2016-03-19,西藏药业独立董事2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_15.pdf
731,2016-03-19,西藏药业董事会审计委员会2015年度履职情况报告,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_18.pdf
732,2016-03-19,西藏药业第五届监事会第十次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_5.pdf
733,2016-03-19,西藏药业第五届董事会第九次会议决议公告,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_2.pdf
734,2016-03-19,西藏药业2015年内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_17.pdf
735,2016-03-19,西藏药业2015年度审计报告,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_13.pdf
736,2016-03-19,西藏药业2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_16.pdf
737,2016-03-19,西藏药业2015年度控股股东及其他关联方占用资金情况的专项说明,/disclosure/listedinfo/announcement/c/2016-03-19/600211_20160319_14.pdf
738,2016-04-01,西藏药业2015年年度股东大会文件,/disclosure/listedinfo/announcement/c/2016-04-01/600211_20160401_1.pdf
739,2016-04-02,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司重大资产出售之2015年度持续督导工作报告书,/disclosure/listedinfo/announcement/c/2016-04-02/600211_20160402_1.pdf
740,2016-04-06,西藏药业关于召开2015年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-04-06/600211_20160406_1.pdf
741,2016-04-06,西藏药业关于公司办公地址变更的公告,/disclosure/listedinfo/announcement/c/2016-04-06/600211_20160406_2.pdf
742,2016-04-09,西藏药业2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-04-09/600211_20160409_1.pdf
743,2016-04-09,西藏药业2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-04-09/600211_20160409_2.pdf
744,2016-04-12,西藏药业重大资产购买报告书（草案）摘要,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_5.pdf
745,2016-04-12,西藏药业重大资产购买报告书（草案）,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_10.pdf
746,2016-04-12,西藏药业未来三年股东回报规划（2016-2018年）,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_16.pdf
747,2016-04-12,西藏药业审计委员会审核意见,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_9.pdf
748,2016-04-12,西藏药业拟购买IMDUR产品相关无形资产组合项目资产评估报告书,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_12.pdf
749,2016-04-12,西藏药业募集资金管理制度（2016年4月修订）,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_14.pdf
750,2016-04-12,西藏药业关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_4.pdf
751,2016-04-12,西藏药业关于依姆多日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_3.pdf
752,2016-04-12,西藏药业非公开发行A股股票募集资金运用的可行性分析报告（修订稿）,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_6.pdf
753,2016-04-12,西藏药业独立董事意见,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_8.pdf
754,2016-04-12,西藏药业独立董事事前认可声明,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_7.pdf
755,2016-04-12,西藏药业第五届监事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_2.pdf
756,2016-04-12,西藏药业第五届董事会第十四次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_1.pdf
757,2016-04-12,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司重大资产购买之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_11.pdf
758,2016-04-12,西藏药业：北京市中伦律师事务所关于西藏诺迪康药业股份有限公司支付现金购买资产暨重大资产重组的法律意见书,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_13.pdf
759,2016-04-12,西藏药业2016年度非公开发行股票预案（修订稿）,/disclosure/listedinfo/announcement/c/2016-04-12/600211_20160412_15.pdf
760,2016-04-21,西藏药业2016年第一次临时股东大会文件,/disclosure/listedinfo/announcement/c/2016-04-21/600211_20160421_1.pdf
761,2016-04-23,西藏药业关于召开2016年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-04-23/600211_20160423_1.pdf
762,2016-04-23,西藏药业2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-23/600211_2016_1.pdf
763,2016-04-28,西藏药业2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-04-28/600211_20160428_1.pdf
764,2016-04-28,西藏药业2016年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-04-28/600211_20160428_2.pdf
765,2016-05-10,西藏药业关于聘任财务总监的独立意见,/disclosure/listedinfo/announcement/c/2016-05-10/600211_20160510_3.pdf
766,2016-05-10,西藏药业关于高级管理人员辞职的公告,/disclosure/listedinfo/announcement/c/2016-05-10/600211_20160510_1.pdf
767,2016-05-10,西藏药业第五届董事会第十五次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-10/600211_20160510_2.pdf
768,2016-05-20,西藏药业审计委员会对非公开发行股票涉及关联交易等相关事项的审核意见,/disclosure/listedinfo/announcement/c/2016-05-20/600211_20160520_9.pdf
769,2016-05-20,西藏药业关于召开2016年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-05-20/600211_20160520_5.pdf
770,2016-05-20,西藏药业关于公司与特定对象签署附条件生效的股份认购协议之补充协议的公告,/disclosure/listedinfo/announcement/c/2016-05-20/600211_20160520_2.pdf
771,2016-05-20,西藏药业关于本次非公开发行A股股票涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2016-05-20/600211_20160520_3.pdf
772,2016-05-20,西藏药业独立董事关于公司非公开发行A股股票涉及关联交易等相关事项的事前认可声明,/disclosure/listedinfo/announcement/c/2016-05-20/600211_20160520_7.pdf
773,2016-05-20,西藏药业独立董事关于公司非公开发行A股股票涉及关联交易等相关事项的独立意见,/disclosure/listedinfo/announcement/c/2016-05-20/600211_20160520_8.pdf
774,2016-05-20,西藏药业第五届监事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-20/600211_20160520_4.pdf
775,2016-05-20,西藏药业第五届董事会第十六次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-05-20/600211_20160520_1.pdf
776,2016-05-20,西藏药业2016年度非公开发行股票预案（三次修订稿）,/disclosure/listedinfo/announcement/c/2016-05-20/600211_20160520_6.pdf
777,2016-05-21,西藏药业关于举行集体接待日的公告,/disclosure/listedinfo/announcement/c/2016-05-21/600211_20160521_1.pdf
778,2016-05-25,西藏药业关于下属全资子公司更名的公告,/disclosure/listedinfo/announcement/c/2016-05-25/600211_20160525_1.pdf
779,2016-05-27,西藏药业2015年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2016-05-27/600211_20160527_1.pdf
780,2016-05-31,西藏药业关于召开2016年第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-05-31/600211_20160531_2.pdf
781,2016-05-31,西藏药业2016年第二次临时股东大会文件,/disclosure/listedinfo/announcement/c/2016-05-31/600211_20160531_1.pdf
782,2016-06-03,西藏药业关于实施2015年度利润分配方案后调整非公开发行股票发行价格和发行数量的公告,/disclosure/listedinfo/announcement/c/2016-06-03/600211_20160603_1.pdf
783,2016-06-07,西藏药业非公开发行A股股票募集资金运用的可行性分析报告（修订稿）,/disclosure/listedinfo/announcement/c/2016-06-07/600211_20160607_4.pdf
784,2016-06-07,西藏药业2016年度非公开发行股票预案（四次修订稿）,/disclosure/listedinfo/announcement/c/2016-06-07/600211_20160607_3.pdf
785,2016-06-07,西藏药业2016年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-06-07/600211_20160607_1.pdf
786,2016-06-07,西藏药业2016年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-06-07/600211_20160607_2.pdf
787,2016-06-18,西藏药业关于收到《中国证监会行政许可申请受理通知书》的公告,/disclosure/listedinfo/announcement/c/2016-06-18/600211_20160618_1.pdf
788,2016-06-24,西藏药业关于收到财政扶持款的公告,/disclosure/listedinfo/announcement/c/2016-06-24/600211_20160624_1.pdf
789,2016-07-09,西藏药业关于吸收合并下属全资子公司的进展公告,/disclosure/listedinfo/announcement/c/2016-07-09/600211_20160709_1.pdf
790,2016-07-21,西藏药业关于收到《中国证监会行政许可项目审查反馈意见通知书》的公告,/disclosure/listedinfo/announcement/c/2016-07-21/600211_20160721_1.pdf
791,2016-08-04,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2016-08-04/600211_20160804_1.pdf
792,2016-08-06,西藏药业信息披露暂缓与豁免业务管理制度,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_12.pdf
793,2016-08-06,西藏药业拟购买IMDUR产品相关无形资产组合项目资产评估报告及评估说明,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_19.pdf
794,2016-08-06,西藏药业监事会议事规则（2015年8月修订）,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_13.pdf
795,2016-08-06,西藏药业及申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司非公开发行股票申请文件反馈意见的回复,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_18.pdf
796,2016-08-06,西藏药业关于最近五年被证券监管部门和交易所采取处罚或监管措施的公告,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_9.pdf
797,2016-08-06,西藏药业关于召开2016年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_7.pdf
798,2016-08-06,西藏药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_3.pdf
799,2016-08-06,西藏药业关于日常关联交易事项调整的公告,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_5.pdf
800,2016-08-06,西藏药业关于改聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_4.pdf
801,2016-08-06,西藏药业关于非公开发行股票未摊薄即期回报及为防范即期回报被摊薄拟采取相关措施的公告,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_6.pdf
802,2016-08-06,西藏药业关于非公开发行股票申请文件反馈意见回复的公告,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_8.pdf
803,2016-08-06,西藏药业公司章程（2016年8月修订）,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_14.pdf
804,2016-08-06,西藏药业独立董事关于日常关联交易事项调整的独立意见,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_16.pdf
805,2016-08-06,西藏药业独立董事关于改聘2016年度财务和内控审计机构的独立意见,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_15.pdf
806,2016-08-06,西藏药业董事会议事规则（2016年8月修订）,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_10.pdf
807,2016-08-06,西藏药业董事会通讯会议实施细则（2016年8月修订）,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_11.pdf
808,2016-08-06,西藏药业第五届监事会第十二次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_2.pdf
809,2016-08-06,西藏药业第五届董事会第十一次会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_1.pdf
810,2016-08-06,西藏药业2016年度非公开发行股票预案（五次修订稿）,/disclosure/listedinfo/announcement/c/2016-08-06/600211_20160806_17.pdf
811,2016-08-13,西藏药业关于终止依姆多持证委托涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2016-08-13/600211_20160813_1.pdf
812,2016-08-13,西藏药业独立董事关于公司关联交易事项的事前认可声明,/disclosure/listedinfo/announcement/c/2016-08-13/600211_20160813_2.pdf
813,2016-08-13,西藏药业独立董事关于公司关联交易事项的独立意见,/disclosure/listedinfo/announcement/c/2016-08-13/600211_20160813_3.pdf
814,2016-08-16,西藏药业关于大股东持有股份被继续冻结的公告,/disclosure/listedinfo/announcement/c/2016-08-16/600211_20160816_2.pdf
815,2016-08-16,西藏药业2016年第三次临时股东大会文件,/disclosure/listedinfo/announcement/c/2016-08-16/600211_20160816_1.pdf
816,2016-08-17,西藏药业关于召开2016年第三次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-08-17/600211_20160817_1.pdf
817,2016-08-19,西藏药业2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-19/600211_2016_zzy.pdf
818,2016-08-19,西藏药业2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-19/600211_2016_z.pdf
819,2016-08-20,西藏药业审计委员会对调整非公开发行股票募集资金总额涉及关联交易等事项的审核意见,/disclosure/listedinfo/announcement/c/2016-08-20/600211_20160820_10.pdf
820,2016-08-20,西藏药业关于召开2016年第四次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-08-20/600211_20160820_5.pdf
821,2016-08-20,西藏药业关于公司与特定对象签署附条件生效的股份认购协议之补充协议（二）的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600211_20160820_4.pdf
822,2016-08-20,西藏药业关于非公开发行股票未摊薄即期回报及为防范即期回报被摊薄拟采取相关措施（修订稿）,/disclosure/listedinfo/announcement/c/2016-08-20/600211_20160820_7.pdf
823,2016-08-20,西藏药业关于调整非公开发行股票募集资金总额涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600211_20160820_3.pdf
824,2016-08-20,西藏药业独立董事关于调整非公开发行股票募集资金总额涉及关联交易等事项的独立意见,/disclosure/listedinfo/announcement/c/2016-08-20/600211_20160820_9.pdf
825,2016-08-20,西藏药业独立董事关于调整非公开发行股票募集资金涉及关联交易等事项的事前认可声明,/disclosure/listedinfo/announcement/c/2016-08-20/600211_20160820_8.pdf
826,2016-08-20,西藏药业第五届监事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-20/600211_20160820_2.pdf
827,2016-08-20,西藏药业第五届董事会第二十次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-08-20/600211_20160820_1.pdf
828,2016-08-20,西藏药业2016年度非公开发行股票预案（六次修订稿）,/disclosure/listedinfo/announcement/c/2016-08-20/600211_20160820_6.pdf
829,2016-08-23,西藏药业2016年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-08-23/600211_20160823_1.pdf
830,2016-08-23,西藏药业2016年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-08-23/600211_20160823_2.pdf
831,2016-08-24,西藏药业与申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司非公开发行股票申请文件反馈意见的回复（修订稿）,/disclosure/listedinfo/announcement/c/2016-08-24/600211_20160824_2.pdf
832,2016-08-24,西藏药业关于非公开发行股票申请文件反馈意见回复修订的公告,/disclosure/listedinfo/announcement/c/2016-08-24/600211_20160824_1.pdf
833,2016-08-30,西藏药业2016年第四次临时股东大会文件,/disclosure/listedinfo/announcement/c/2016-08-30/600211_20160830_1.pdf
834,2016-08-31,西藏药业关于召开2016年第四次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-08-31/600211_20160831_1.pdf
835,2016-09-06,西藏药业2016年第四次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-09-06/600211_20160906_1.pdf
836,2016-09-06,西藏药业2016年第四次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-09-06/600211_20160906_2.pdf
837,2016-09-20,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2016-09-20/600211_20160920_1.pdf
838,2016-10-11,西藏药业关于收到《中国证监会行政许可项目审查二次反馈意见通知书》的公告,/disclosure/listedinfo/announcement/c/2016-10-11/600211_20161011_1.pdf
839,2016-10-13,西藏药业及申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司非公开发行股票申请文件二次反馈意见的回复,/disclosure/listedinfo/announcement/c/2016-10-13/600211_20161013_2.pdf
840,2016-10-13,西藏药业关于非公开发行股票申请文件二次反馈意见回复的公告,/disclosure/listedinfo/announcement/c/2016-10-13/600211_20161013_1.pdf
841,2016-10-20,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2016-10-20/600211_20161020_1.pdf
842,2016-10-21,西藏药业第五届董事会第二十一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2016-10-21/600211_20161021_1.pdf
843,2016-10-28,西藏药业2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-28/600211_2016_3.pdf
844,2016-10-31,西藏药业及申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司非公开发行股票申请文件补充反馈意见的回复,/disclosure/listedinfo/announcement/c/2016-10-31/600211_20161031_2.pdf
845,2016-10-31,西藏药业关于非公开发行股票申请文件反馈意见补充回复的公告,/disclosure/listedinfo/announcement/c/2016-10-31/600211_20161031_1.pdf
846,2016-11-07,西藏药业关于非公开发行股票申请文件反馈意见第二次补充回复的公告,/disclosure/listedinfo/announcement/c/2016-11-07/600211_20161107_1.pdf
847,2016-11-07,西藏药业：关于西藏诺迪康药业股份有限公司非公开发行股票申请文件第二次补充反馈意见的回复,/disclosure/listedinfo/announcement/c/2016-11-07/600211_20161107_2.pdf
848,2016-11-17,西藏药业关于非公开发行A股股票申请获得中国证监会发行审核委员会审核通过的公告,/disclosure/listedinfo/announcement/c/2016-11-17/600211_20161117_1.pdf
849,2016-11-22,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2016-11-22/600211_20161122_1.pdf
850,2016-11-29,西藏药业关于大股东更名及相关工商登记事项变更的公告,/disclosure/listedinfo/announcement/c/2016-11-29/600211_20161129_1.pdf
851,2016-12-17,西藏药业对外投资公告,/disclosure/listedinfo/announcement/c/2016-12-17/600211_20161217_1.pdf
852,2016-12-22,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2016-12-22/600211_20161222_2.pdf
853,2016-12-22,西藏药业关于设立全资子公司的公告,/disclosure/listedinfo/announcement/c/2016-12-22/600211_20161222_1.pdf
854,2016-12-27,西藏药业关于获得产业发展扶持资金的公告,/disclosure/listedinfo/announcement/c/2016-12-27/600211_20161227_1.pdf
855,2016-12-30,西藏药业对外投资公告,/disclosure/listedinfo/announcement/c/2016-12-30/600211_20161230_1.pdf
856,2016-12-30,西藏药业对外投资的补充公告,/disclosure/listedinfo/announcement/c/2016-12-30/600211_20161230_2.pdf
857,2017-01-21,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-01-21/600211_20170121_1.pdf
858,2017-01-24,西藏药业：国都证券股份有限公司关于西藏诺迪康药业股份有限公司股权分置改革2016年年度保荐工作报告书,/disclosure/listedinfo/announcement/c/2017-01-24/600211_20170124_1.pdf
859,2017-01-26,西藏药业2016年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-01-26/600211_20170126_1.pdf
860,2017-02-07,西藏药业为全资子公司贷款提供担保的公告,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_6.pdf
861,2017-02-07,西藏药业审计委员会对再次调整非公开发行股票募集资金总额涉及关联交易等事项的审核意见,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_13.pdf
862,2017-02-07,西藏药业审计委员会对归还并购借款涉及关联交易的审核意见,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_16.pdf
863,2017-02-07,西藏药业关于召开2017年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_7.pdf
864,2017-02-07,西藏药业关于再次调整非公开发行股票募集资金总额涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_2.pdf
865,2017-02-07,西藏药业关于归还并购借款涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_5.pdf
866,2017-02-07,西藏药业关于公司与特定对象签署附条件生效的股份认购协议之补充协议（三）的公告,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_3.pdf
867,2017-02-07,西藏药业关于非公开发行股票未摊薄即期回报及为防范即期回报被摊薄拟采取相关措施（二次修订稿）,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_9.pdf
868,2017-02-07,西藏药业非公开发行A股股票募集资金运用的可行性分析报告（二次修订稿）,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_10.pdf
869,2017-02-07,西藏药业独立董事关于再次调整非公开发行股票募集资金总额涉及关联交易等事项的事前认可声明,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_11.pdf
870,2017-02-07,西藏药业独立董事关于再次调整非公开发行股票募集资金总额涉及关联交易等事项的独立意见,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_12.pdf
871,2017-02-07,西藏药业独立董事关于为全资子公司贷款提供担保的独立意见,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_17.pdf
872,2017-02-07,西藏药业独立董事关于归还并购借款涉及关联交易事项的事前认可声明,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_14.pdf
873,2017-02-07,西藏药业独立董事关于归还并购借款涉及关联交易事项的独立意见,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_15.pdf
874,2017-02-07,西藏药业第五届监事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_4.pdf
875,2017-02-07,西藏药业第五届董事会第二十四次临时会议决议公告,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_1.pdf
876,2017-02-07,西藏药业2016年度非公开发行股票预案（七次修订稿）,/disclosure/listedinfo/announcement/c/2017-02-07/600211_20170207_8.pdf
877,2017-02-10,西藏药业关于归还并购借款涉及关联交易的补充公告,/disclosure/listedinfo/announcement/c/2017-02-10/600211_20170210_1.pdf
878,2017-02-16,西藏药业2017年第一次临时股东大会文件,/disclosure/listedinfo/announcement/c/2017-02-16/600211_20170216_1.pdf
879,2017-02-18,西藏药业关于召开2017年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-02-18/600211_20170218_1.pdf
880,2017-02-21,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-02-21/600211_20170221_1.pdf
881,2017-02-23,西藏药业关于非公开发行股票会后事项说明的公告,/disclosure/listedinfo/announcement/c/2017-02-23/600211_20170223_1.pdf
882,2017-02-23,西藏药业关于非公开发行股票会后事项的说明,/disclosure/listedinfo/announcement/c/2017-02-23/600211_20170223_4.pdf
883,2017-02-23,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司非公开发行股票会后事项的核查意见,/disclosure/listedinfo/announcement/c/2017-02-23/600211_20170223_5.pdf
884,2017-02-23,西藏药业：北京市中伦律师事务所关于西藏诺迪康药业股份有限公司非公开发行项目会后重大事项的法律意见书,/disclosure/listedinfo/announcement/c/2017-02-23/600211_20170223_6.pdf
885,2017-02-23,西藏药业2017年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-02-23/600211_20170223_2.pdf
886,2017-02-23,西藏药业2017年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-02-23/600211_20170223_3.pdf
887,2017-02-25,西藏药业关于非公开发行股票会后事项说明补充修订的公告,/disclosure/listedinfo/announcement/c/2017-02-25/600211_20170225_1.pdf
888,2017-02-25,西藏药业关于非公开发行股票会后事项的说明（修订稿）,/disclosure/listedinfo/announcement/c/2017-02-25/600211_20170225_2.pdf
889,2017-02-25,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司非公开发行股票会后事项的核查意见（修订稿）,/disclosure/listedinfo/announcement/c/2017-02-25/600211_20170225_3.pdf
890,2017-02-25,西藏药业：北京市中伦律师事务所关于西藏诺迪康药业股份有限公司非公开发行项目会后重大事项的法律意见书（修订稿）,/disclosure/listedinfo/announcement/c/2017-02-25/600211_20170225_4.pdf
891,2017-03-22,西藏药业审计委员会对公司关联交易事项的审核意见,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_18.pdf
892,2017-03-22,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_7.pdf
893,2017-03-22,西藏药业关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_6.pdf
894,2017-03-22,西藏药业关于延长公司非公开发行股票决议有效期及授权有效期的公告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_5.pdf
895,2017-03-22,西藏药业关于日常关联交易预计的公告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_4.pdf
896,2017-03-22,西藏药业独立董事关于公司关联交易事项的事前认可声明,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_16.pdf
897,2017-03-22,西藏药业独立董事对2016年年报及相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_17.pdf
898,2017-03-22,西藏药业独立董事2016年度述职报告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_11.pdf
899,2017-03-22,西藏药业董事会审计委员会2016年度履职情况报告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_15.pdf
900,2017-03-22,西藏药业第五届监事会第十五次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_3.pdf
901,2017-03-22,西藏药业第五届董事会第十四次会议决议公告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_2.pdf
902,2017-03-22,西藏药业：内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_14.pdf
903,2017-03-22,西藏药业：关于西藏诺迪康药业股份有限公司盈利预测实现情况的专项审核报告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_13.pdf
904,2017-03-22,西藏药业：关于西藏诺迪康药业股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审核报告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_10.pdf
905,2017-03-22,西藏药业：财务报表审计报告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_9.pdf
906,2017-03-22,西藏药业2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-03-22/600211_2016_nzy.pdf
907,2017-03-22,西藏药业2016年年度报告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_2016_n.pdf
908,2017-03-22,西藏药业2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-03-22/600211_20170322_12.pdf
909,2017-03-28,西藏药业关于非公开发行股票会后事项的补充说明,/disclosure/listedinfo/announcement/c/2017-03-28/600211_20170328_2.pdf
910,2017-03-28,西藏药业关于非公开发行股票会后事项补充说明的公告,/disclosure/listedinfo/announcement/c/2017-03-28/600211_20170328_1.pdf
911,2017-03-28,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司非公开发行股票会后事项的补充核查意见,/disclosure/listedinfo/announcement/c/2017-03-28/600211_20170328_3.pdf
912,2017-03-28,西藏药业：瑞华会计师事务所（特殊普通合伙）关于西藏诺迪康药业股份有限公司非公开发行股票的会后重大事项说明,/disclosure/listedinfo/announcement/c/2017-03-28/600211_20170328_5.pdf
913,2017-03-28,西藏药业：北京市中伦律师事务所关于西藏诺迪康药业股份有限公司非公开发行项目会后重大事项的法律意见书（二）,/disclosure/listedinfo/announcement/c/2017-03-28/600211_20170328_4.pdf
914,2017-03-31,西藏药业2016年度利润分配投资者说明会预告公告,/disclosure/listedinfo/announcement/c/2017-03-31/600211_20170331_1.pdf
915,2017-04-06,西藏药业审计委员会对收购依姆多资产后续资金安排涉及关联交易的审核意见,/disclosure/listedinfo/announcement/c/2017-04-06/600211_20170406_7.pdf
916,2017-04-06,西藏药业关于收购依姆多资产后续资金安排涉及关联交易的公告,/disclosure/listedinfo/announcement/c/2017-04-06/600211_20170406_2.pdf
917,2017-04-06,西藏药业关于非公开发行股票会后事项的补充说明（二）,/disclosure/listedinfo/announcement/c/2017-04-06/600211_20170406_9.pdf
918,2017-04-06,西藏药业关于非公开发行股票会后事项补充说明（二）的公告,/disclosure/listedinfo/announcement/c/2017-04-06/600211_20170406_4.pdf
919,2017-04-06,西藏药业关于2016年年度股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2017-04-06/600211_20170406_3.pdf
920,2017-04-06,西藏药业独立董事关于收购依姆多资产后续资金安排涉及关联交易事项的事前认可声明,/disclosure/listedinfo/announcement/c/2017-04-06/600211_20170406_5.pdf
921,2017-04-06,西藏药业独立董事关于收购依姆多资产后续资金安排涉及关联交易事项的独立意见,/disclosure/listedinfo/announcement/c/2017-04-06/600211_20170406_6.pdf
922,2017-04-06,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司重大资产重组之2016年度持续督导工作报告书,/disclosure/listedinfo/announcement/c/2017-04-06/600211_20170406_1.pdf
923,2017-04-06,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司非公开发行股票会后事项的补充核查意见（二）,/disclosure/listedinfo/announcement/c/2017-04-06/600211_20170406_10.pdf
924,2017-04-06,西藏药业：北京市中伦律师事务所关于西藏诺迪康药业股份有限公司非公开发行项目会后重大事项的法律意见书（三）,/disclosure/listedinfo/announcement/c/2017-04-06/600211_20170406_11.pdf
925,2017-04-06,西藏药业：IMDUR产品相关无形资产组合评估项目资产评估报告及评估说明,/disclosure/listedinfo/announcement/c/2017-04-06/600211_20170406_8.pdf
926,2017-04-08,西藏药业关于收到中国证监会核准非公开发行股票批文的公告,/disclosure/listedinfo/announcement/c/2017-04-08/600211_20170408_2.pdf
927,2017-04-08,西藏药业2016年年度股东大会文件,/disclosure/listedinfo/announcement/c/2017-04-08/600211_20170408_1.pdf
928,2017-04-11,西藏药业关于召开2016年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-04-11/600211_20170411_1.pdf
929,2017-04-15,西藏药业2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-04-15/600211_20170415_1.pdf
930,2017-04-15,西藏药业2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-04-15/600211_20170415_2.pdf
931,2017-04-18,西藏药业关于参加国家医保目录价格谈判的公告,/disclosure/listedinfo/announcement/c/2017-04-18/600211_20170418_1.pdf
932,2017-04-22,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-04-22/600211_20170422_1.pdf
933,2017-04-27,西藏药业2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-27/600211_2017_1.pdf
934,2017-05-05,西藏药业收购报告书摘要,/disclosure/listedinfo/announcement/c/2017-05-05/600211_20170505_7.pdf
935,2017-05-05,西藏药业收购报告书,/disclosure/listedinfo/announcement/c/2017-05-05/600211_20170505_9.pdf
936,2017-05-05,西藏药业关于股东权益变动的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-05/600211_20170505_10.pdf
937,2017-05-05,西藏药业非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2017-05-05/600211_20170505_6.pdf
938,2017-05-05,西藏药业非公开发行股票发行结果暨股份变动公告,/disclosure/listedinfo/announcement/c/2017-05-05/600211_20170505_1.pdf
939,2017-05-05,西藏药业：验资报告,/disclosure/listedinfo/announcement/c/2017-05-05/600211_20170505_3.pdf
940,2017-05-05,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司非公开发行股票发行过程和认购对象合规性报告,/disclosure/listedinfo/announcement/c/2017-05-05/600211_20170505_5.pdf
941,2017-05-05,西藏药业：东莞证券股份有限公司关于西藏诺迪康药业股份有限公司收购报告书之财务顾问核查意见,/disclosure/listedinfo/announcement/c/2017-05-05/600211_20170505_8.pdf
942,2017-05-05,西藏药业：北京市中伦律师事务所关于西藏诺迪康药业股份有限公司非公开发行A股股票发行过程和认购对象合规性的法律意见书,/disclosure/listedinfo/announcement/c/2017-05-05/600211_20170505_2.pdf
943,2017-05-05,西藏药业：北京市中伦律师事务所关于西藏康哲企业管理有限公司及其一致行动人免于提交豁免要约收购申请的专项核查意见,/disclosure/listedinfo/announcement/c/2017-05-05/600211_20170505_4.pdf
944,2017-05-09,西藏药业独立董事关于聘任公司高级管理人员的独立意见,/disclosure/listedinfo/announcement/c/2017-05-09/600211_20170509_2.pdf
945,2017-05-09,西藏药业第六届监事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-09/600211_20170509_3.pdf
946,2017-05-09,西藏药业第六届董事会第一次会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-09/600211_20170509_1.pdf
947,2017-05-13,西藏药业股改限售股上市流通公告,/disclosure/listedinfo/announcement/c/2017-05-13/600211_20170513_1.pdf
948,2017-05-13,西藏药业：国都证券关于西藏药业股权分置改革限售股上市流通申请的专项核查意见,/disclosure/listedinfo/announcement/c/2017-05-13/600211_20170513_2.pdf
949,2017-05-17,西藏药业关于召开2017年第二次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-05-17/600211_20170517_9.pdf
950,2017-05-17,西藏药业关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2017-05-17/600211_20170517_6.pdf
951,2017-05-17,西藏药业关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2017-05-17/600211_20170517_4.pdf
952,2017-05-17,西藏药业关于利用闲置资金购买理财产品的公告,/disclosure/listedinfo/announcement/c/2017-05-17/600211_20170517_7.pdf
953,2017-05-17,西藏药业公司章程（2017年5月修订）,/disclosure/listedinfo/announcement/c/2017-05-17/600211_20170517_5.pdf
954,2017-05-17,西藏药业独立董事对第六届董事会第一次临时会议相关事项的独立意见,/disclosure/listedinfo/announcement/c/2017-05-17/600211_20170517_2.pdf
955,2017-05-17,西藏药业第六届监事会第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-17/600211_20170517_3.pdf
956,2017-05-17,西藏药业第六届董事会第一次临时会议决议公告,/disclosure/listedinfo/announcement/c/2017-05-17/600211_20170517_1.pdf
957,2017-05-17,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司利用闲置资金购买理财产品的核查意见,/disclosure/listedinfo/announcement/c/2017-05-17/600211_20170517_8.pdf
958,2017-05-20,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-05-20/600211_20170520_1.pdf
959,2017-05-23,西藏药业关于签订募集资金专户存储三方监管协议的公告,/disclosure/listedinfo/announcement/c/2017-05-23/600211_20170523_1.pdf
960,2017-05-24,西藏药业关于召开2017年第二次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-05-24/600211_20170524_2.pdf
961,2017-05-24,西藏药业2017年第二次临时股东大会文件,/disclosure/listedinfo/announcement/c/2017-05-24/600211_20170524_1.pdf
962,2017-06-02,西藏药业关于举行集体接待日的公告,/disclosure/listedinfo/announcement/c/2017-06-02/600211_20170602_4.pdf
963,2017-06-02,西藏药业：国都证券股份有限公司关于西藏诺迪康药业股份有限公司股权分置改革持续督导之保荐总结报告书,/disclosure/listedinfo/announcement/c/2017-06-02/600211_20170602_1.pdf
964,2017-06-02,西藏药业2017年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-02/600211_20170602_2.pdf
965,2017-06-02,西藏药业2017年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-06-02/600211_20170602_3.pdf
966,2017-06-06,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-06-06/600211_20170606_1.pdf
967,2017-06-10,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-06-10/600211_20170610_1.pdf
968,2017-06-22,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-06-22/600211_20170622_1.pdf
969,2017-07-20,西藏药业关于参加国家医保目录价格谈判的进展公告,/disclosure/listedinfo/announcement/c/2017-07-20/600211_20170720_1.pdf
970,2017-07-22,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-07-22/600211_20170722_1.pdf
971,2017-07-22,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-07-22/600211_20170722_2.pdf
972,2017-07-26,西藏药业关于股东持有股份解除质押的公告,/disclosure/listedinfo/announcement/c/2017-07-26/600211_20170726_1.pdf
973,2017-08-17,西藏药业重大诉讼进展公告,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_15.pdf
974,2017-08-17,西藏药业审计委员会对日常关联交易事项调整的审核意见,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_8.pdf
975,2017-08-17,西藏药业日常关联交易事项调整的公告,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_5.pdf
976,2017-08-17,西藏药业监事会关于执行新企业会计准则导致会计政策变更的意见,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_10.pdf
977,2017-08-17,西藏药业关于执行新企业会计准则导致会计政策变更的公告,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_9.pdf
978,2017-08-17,西藏药业关于召开2017年第三次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_12.pdf
979,2017-08-17,西藏药业关于公司募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_4.pdf
980,2017-08-17,西藏药业独立董事关于执行新企业会计准则导致会计政策变更事项的独立意见,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_11.pdf
981,2017-08-17,西藏药业独立董事关于日常关联交易事项调整的事前认可声明,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_6.pdf
982,2017-08-17,西藏药业独立董事关于日常关联交易事项调整的独立意见,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_7.pdf
983,2017-08-17,西藏药业独立董事关于2017年半年度利润分配预案的独立意见,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_2.pdf
984,2017-08-17,西藏药业第六届监事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_3.pdf
985,2017-08-17,西藏药业第六届董事会第二次会议决议公告,/disclosure/listedinfo/announcement/c/2017-08-17/600211_20170817_1.pdf
986,2017-08-17,西藏药业2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-17/600211_2017_zzy.pdf
987,2017-08-17,西藏药业2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-17/600211_2017_z.pdf
988,2017-08-22,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-08-22/600211_20170822_1.pdf
989,2017-08-25,西藏药业2017年第三次临时股东大会文件,/disclosure/listedinfo/announcement/c/2017-08-25/600211_20170825_1.pdf
990,2017-08-29,西藏药业关于召开2017年第三次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2017-08-29/600211_20170829_1.pdf
991,2017-08-31,西藏药业关于重大资产重组实施进展总体情况的公告,/disclosure/listedinfo/announcement/c/2017-08-31/600211_20170831_1.pdf
992,2017-08-31,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司重大资产重组实施进展情况的核查意见,/disclosure/listedinfo/announcement/c/2017-08-31/600211_20170831_3.pdf
993,2017-08-31,西藏药业：北京市中伦（深圳）律师事务所关于西藏诺迪康药业股份有限公司支付现金购买资产暨重大资产重组实施进展情况的法律意见书,/disclosure/listedinfo/announcement/c/2017-08-31/600211_20170831_2.pdf
994,2017-09-02,西藏药业2017年第三次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-09-02/600211_20170902_1.pdf
995,2017-09-02,西藏药业2017年第三次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-09-02/600211_20170902_2.pdf
996,2017-09-12,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-09-12/600211_20170912_1.pdf
997,2017-09-13,西藏药业用募集资金置换预先投入的自筹资金的公告,/disclosure/listedinfo/announcement/c/2017-09-13/600211_20170913_1.pdf
998,2017-09-13,西藏药业独立董事关于使用募集资金置换预先投入的自筹资金的独立意见,/disclosure/listedinfo/announcement/c/2017-09-13/600211_20170913_2.pdf
999,2017-09-13,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司使用募集资金置换预先投入募投项目自筹资金的核查意见,/disclosure/listedinfo/announcement/c/2017-09-13/600211_20170913_3.pdf
1000,2017-09-13,西藏药业：瑞华会计师事务所关于西藏诺迪康药业股份有限公司以自筹资金预先投入募集资金投资项目情况报告的鉴证报告,/disclosure/listedinfo/announcement/c/2017-09-13/600211_20170913_4.pdf
1001,2017-09-22,西藏药业2017年半年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-09-22/600211_20170922_1.pdf
1002,2017-09-30,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-09-30/600211_20170930_2.pdf
1003,2017-09-30,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-09-30/600211_20170930_3.pdf
1004,2017-09-30,西藏药业关于举行集体接待日公告,/disclosure/listedinfo/announcement/c/2017-09-30/600211_20170930_1.pdf
1005,2017-10-12,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-10-12/600211_20171012_1.pdf
1006,2017-10-21,西藏药业关于获得扶持资金的公告,/disclosure/listedinfo/announcement/c/2017-10-21/600211_20171021_1.pdf
1007,2017-10-24,西藏药业关于归还收购依姆多资产借款的公告,/disclosure/listedinfo/announcement/c/2017-10-24/600211_20171024_1.pdf
1008,2017-10-28,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-10-28/600211_20171028_1.pdf
1009,2017-10-28,西藏药业2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-28/600211_2017_3.pdf
1010,2017-10-31,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-10-31/600211_20171031_1.pdf
1011,2017-11-02,西藏药业关于大股东持有股份被解除冻结的公告,/disclosure/listedinfo/announcement/c/2017-11-02/600211_20171102_1.pdf
1012,2017-11-03,西藏药业关于获得产业发展扶持资金的公告,/disclosure/listedinfo/announcement/c/2017-11-03/600211_20171103_1.pdf
1013,2017-11-16,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-11-16/600211_20171116_1.pdf
1014,2017-11-21,西藏药业关于大股东持有股份被解除冻结的公告,/disclosure/listedinfo/announcement/c/2017-11-21/600211_20171121_1.pdf
1015,2017-11-30,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-11-30/600211_20171130_1.pdf
1016,2017-12-12,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-12-12/600211_20171212_1.pdf
1017,2017-12-23,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-12-23/600211_20171223_1.pdf
1018,2017-12-27,西藏药业：申万宏源证券承销保荐有限责任公司关于西藏诺迪康药业股份有限公司2017年度持续督导现场检查报告,/disclosure/listedinfo/announcement/c/2017-12-27/600211_20171227_1.pdf
1019,2017-12-30,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2017-12-30/600211_20171230_1.pdf
1020,2017-12-30,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2017-12-30/600211_20171230_2.pdf
1021,2018-01-06,西藏药业关于使用闲置资金购买理财产品的进展公告,/disclosure/listedinfo/announcement/c/2018-01-06/600211_20180106_1.pdf
1022,2018-01-31,西藏药业关于重大资产重组实施进展的公告,/disclosure/listedinfo/announcement/c/2018-01-31/600211_20180131_1.pdf
1023,2018-02-10,西藏药业关于获得产业发展扶持资金的公告,/disclosure/listedinfo/announcement/c/2018-02-10/600211_20180210_1.pdf
1024,2018-02-13,西藏药业关于全资子公司增资扩股变更手续办理完成的公告,/disclosure/listedinfo/announcement/c/2018-02-13/600211_20180213_1.pdf
